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Protein self-assembly is a versatile bottom-up strategy to build biological 
materials. It is mediated by non-covalent interactions, which are involved in formation of 
diverse biological materials in nature. Inspired by the principle, we developed strategies 
for self-assembly of protein-based suprastructures from recombinant protein building 
blocks. The suprastructures were designed as modular systems which enable 
incorporation folded functional proteins. Morphology of the suprastructures was 
manipulated into spheres, vesicles, nanosheets and porous particles, by engineering 
protein building blocks, controlling self-assembly processes, and combining inorganic 
nanocrystals into hybrid materials.  
First, we demonstrated self-assembly of spherical protein coacervates in the 
extracellular matrix (ECM). It is an in-situ protein self-assembly system, which is 
mediated by spontaneous diffusion–coacervation and high-affinity binding of 
recombinant protein building blocks. The self-assembled protein particles are entrapped, 
shrank, and dissociated in the ECM, providing a potential as a “carrier-free” protein 
delivery system. 
Second, we developed a strategy for self-assembly of vesicles from folded 
proteins. In aqueous solution, recombinant protein complex amphiphiles self-assembled 
into hollow vesicles via temperature-responsive inverse phase transition. Preferential 
encapsulation of various cargo can be achieved, which include protein coacervates, small 
molecules, and nanoparticles. Our strategy offers a versatile method to create protein-
based delivery vehicles with biological functionality. 
 xxi 
Third, self-assembly of 2D nanosheets was demonstrated. Under controlled 
processes, designed recombinant protein building blocks self-assembled into nanosheets. 
For example, drying method induced formation of large protein sheets. Also, full-length 
folded functional protein domains were able to be incorporated. 
Lastly, we developed hierarchically structured porous protein-inorganic hybrid 
supraparticles. Self-clustering hybrid flower-shaped nanoparticles were prepared, and 
their assembly into porous particles with complex morphology was controlled at the air-
water interface. The incorporated proteins in the hybrid material provide high-affinity 
binding sites. Various proteins can be immobilized, and we investigated immobilization 
of a protease. When immobilized, the enzyme showed enhanced inactivation of a pro-
inflammatory cytokine, tumor necrosis factor-α (TNF-α). 
Overall, we demonstrated new approaches to create protein-based suprastructures. 
Also, we provided fundamentals which are critical and specific for self-assembly of the 
developed suprastructures. The modular design approach for integration of diverse 










1.1 Self-Assembled Protein Biomaterials 
 Self-assembly is defined as the autonomous process during which components 
self-organize into structures.
1
 It is mediated by non-covalent interactions including 
hydrogen bonds, electrostatic interactions, hydrophobic interactions, and van der Waals 
interactions.
2
 Proteins are biopolymers which have weak non-covalent interactions to 
carry out biological functions. For example, receptor–ligand binding interactions regulate 
diverse biological processes,
3
 and antibodies identify and neutralize antigens in the 
immune system.
4
 In addition, structural scaffolds in the body are built from self-
assembled proteins. In the extracellular matrix (ECM), collagens are present as self-
assembled fibrils and provide mechanical strength.
5
 Laminins are cross-shaped proteins 
that self-assemble into cell-associated networks in basement membranes.
6
 Amelogenin, 
the ECM protein in dental enamel, undergoes stepwise assembly into high-order 
structures via cooperative interactions with minerals.
7
 Indeed, protein self-assembly is 
how nature builds biological materials. 
 Natural protein biomaterials have been extensively used for regenerative medicine 
and tissue engineering.
8,9
 However, direct harvest and use of these materials have 
shortcomings including limitations in tuning their properties,
10
 long processing times 
with increasing cost of production,
11
 and complexity associated with purification.
12
 As an 
alternative, recombinant protein engineering offers a number of advantages. Recombinant 
DNA technology is a powerful tool to engineer proteins. Primary structure can be 
modified by changing the amino acid sequence, and it can lead to engineering of 
secondary, tertiary, quaternary structure, and the consequent function. Also, methods for 
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high-yield expression and purification of recombinant proteins have been established, 
providing benefits over natural proteins.
13,14
 
 Importantly, recombinant proteins can be customized to self-assemble into 
biomaterials with properties tuned for specific applications. Tuning of self-assembling 
protein domains can allow the subsequent control in the resulting material properties.
15
 
Also, multiple domains can be combined by a modular design approach. It enables 
incorporation of diverse structural and functional domains in a single protein building 
block.
10
 The growing interest and advances in recombinant protein technology are 
predicted to allow creation of biomaterials with diverse and sophisticated physical and 
biological properties. 
 
1.2 Biological Functionality of Biomaterials 
 Biological functionality of biomaterials is the requirement for effective regulation 
of signaling in biological environments. Elaboration of such materials that can 
manipulate biological signals has become a growing trend in biomaterial design.
12
 In 
general, biological functionality of materials is achieved by incorporation of moieties for 
biological recognition that include cellular adhesion, receptor-binding, and 
proteolysis.
10,12,16
 For example, presentation of cell-binding domains greatly influences 
cell morphology and behaviors.
17,18
 Tethered growth factors regulates functions of cells 
that interact with the material.
19
 A convenient strategy is incorporation of functional 
peptides.
10,16
 They can be chemically conjugated to synthetic polymers or the specific 
amino acid sequences can be inserted into the sequence of peptides or proteins. There has 
been a rapid increase in the library of biofunctional domains, which continues to expand 
through repurposing of the original known functionality.
10
 
 On the other hand, biological functionality of full-length folded proteins can be 
superior to those from peptides. For example, biocatalytic properties are difficult to 
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achieve by incorporation of peptides. Although physical entrapment of folded proteins 
inside biomaterials can be a simple approach, sustained release of proteins is often 
required.
20
 Chemical conjugation of proteins to materials can be an alternative, but the 
conjugation processes might hamper protein activity.
21
 Self-assembly can be a powerful 
strategy for specific incorporation of folded proteins in biocompatible environments. 
Nevertheless, such strategies remain underdeveloped. A few recent studies have 
illustrated self-assembled protein biomaterials that carry full-length folded proteins, 
including enzymes, antigens,
22
 and protein therapeutics.
23
 This new approach has 
significant implications in development of biomaterials with enhanced biological 
functionality. It is predicted to offer new opportunities in tissue engineering, vaccination, 
and drug delivery. 
 
1.3 Physical Properties of Biomaterials 
 Besides biological properties, physical properties of biomaterials have also been 
recognized to regulate biological responses.
24
 There is a growing interest in size, shape, 
mechanical properties, and surface topology. New design parameters related to these 
physical properties of biomaterials can be used to control biological responses. For 




 in vivo. 




 as the 
local geometry of particles dictate initiation of internalization. Elasticity and stiffness of 
biomaterials has been reported to influence development and growth of cellular 
architecture.
29,30
 Also, it has been established that surface topology plays a decisive role 
in cell morphology, adhesion or motility.
31
 
  Self-assembly is a versatile “bottom-up” strategy to fabricate biomaterials with 
controlled morphologies at nano- and micrometer length scales.
2
 In nature, we can find 
many examples of self-assembled protein nano- and microstructures, including 
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microtubules, viruses, clathrin lattices, and actin filaments.
32
 Similarly, protein motifs 







 and even more complex structures
36
 have been 
assembled from engineered protein building blocks. Furthermore, a computational 
method enabled the design of self-assembled protein nanostructures with high accuracy.
37
 
Although the tuned protein structures have been demonstrated in fundamental aspects, 
their structural features have a great potential in applications. In fact, self-assembled 




1.4 Motivations and Objectives 
 As discussed in the previous sections, consideration of both biological and 
physical properties of protein biomaterial is essential for practical applications. However, 
development of self-assembled protein biomaterials has mainly focused on bulk materials 
such as hydrogels. Also, incorporation of folded proteins into building blocks is 
challenging because balancing self-assembling property and biological function in a 
single building block is difficult to achieve. For example, self-assembling proteins, which 
were created using protein design strategies, are lack of biological functionality,
35,37
 or a 
simple type of assembly has only been achieved using functional proteins.
39
 Therefore, 
nano- and microstructured colloidal protein particles that carry full-length folded proteins 
would be a new generation of biomaterials with enhanced control over both physical and 
biological properties. This approach can reduce the potential adverse effects such as 
toxicity concerns,
40




 which can be 
caused by use of synthetic or biological bulk materials. In a recent study, self-assembled 
protein nanoparticles containing a growth factor showed an enhanced performance in 
wound treatment, eliminating the use of scaffold materials.
39
 In this thesis, I demonstrate 
development of protein-based colloidal suprastructures with controlled morphologies. It 
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is a generalized system that incorporates folded proteins as part of the building blocks. 
Self-assembly of recombinant protein can significantly simplify steps required for 
material fabrication. It also provides biocompatible environments which are necessary for 
use of folded proteins. Also, well-established methods are available for production of 
recombinant proteins in reasonable quantities.   
 The objectives of this thesis are summarized as: (1) creation and production of 
recombinant protein building blocks and understanding of their self-assembly into 
protein-based colloidal suprastructures, (2) development of a modular and generalized 
system to incorporate fully folded and functional proteins into the suprastructures, (3) 
control of their morphology at nano- and micrometer length scale, (4) use for a practical 
application. 
 
1.5 Thesis Overview 
 To achieve the objectives, I designed and produced recombinant fusion proteins 
which combine different types of protein motifs and domains: leucine zipper coiled coils, 
elastin-like polypeptides, random coils, fluorescent proteins, and enzymes. Depending on 
the nature of protein building blocks or controls in self-assembly processes, the 
morphology of colloidal suprastructures was manipulated into spheres, vesicles, 
nanosheets, and porous particles. All of the suprastructures were created as modular 
systems that can integrate fusion proteins containing fully folded globular domains, 
demonstrated here with fluorescent proteins or enzymes. 
 In Chapter 2, a brief introduction of the protein motifs and domains used in this 
thesis is provided. Design rationales for the fusion proteins are discussed, followed by a 
description of experimental details for cloning, expression, and purification. In Chapter 3, 
a protein self-assembly strategy in the ECM is described. It is a concept of “carrier-free” 
protein delivery, where transport of proteins in the ECM is controlled by their self-
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assembly inside the matrix. Chapter 4 illustrates the thermally triggered self-assembly of 
folded proteins into vesicles. They incorporate globular proteins in the vesicular 
membrane, and can encapsulate small molecules, proteins, and nanoparticles. Chapter 5 
presents a strategy to fabricate protein nanosheets via template-assisted self-assembly. 
Chapter 6 describes hierarchically structured protein-inorganic hybrid supraparticles that 
are assembled from flower-shaped hybrid nanoparticles. In Chapter 7, Immobilization 
and characterization of a cysteine protease is demonstrated as an application for cytokine 
inactivation. In Chapter 8, contributions of this thesis are summarized, and recommended 




BIOSYNTHESIS OF RECOMBINANT FUSION PROTEINS 
2.1 Biomimetic Protein Motifs 
2.1.1 Coiled Coils 
 Coiled coils are superhelical protein motifs composed of two or more assembled 
α-helical peptides.
42
 They are structural motifs that mediate oligomerization of subunits, 
and analysis indicates approximately 2–3% of all protein residues form coiled coils.
43,44
 
The primary structure of the coiled coil is the heptad repeat pattern (abcdefg)n where n is 
the number of repeats.
42
 Hydrophobic amino acids are positioned at a and d, which form 
the tightly packed hydrophobic core of the coiled coils (Figure 2.1). Amino acids with 
complementary charged side groups occupy the positions e and g. The interaction of side 
chains at e and g forms the stabilizing interstrand salt bridge. Leucine zippers are dimeric 
coiled coils which mediate dimerization of the DNA binding domains (bZIP and bHLH-
ZIP) in transcription factors.
45-47
 Occupation of the position d by leucine residues is the 
characteristic of leucine zippers, which is critical for dimerization.
47,48
 Among the 
artificially designed leucine zippers is a hetero-dimerizing leucine zipper pair that forms a 




 which compares to the 
affinity between streptavidin and biotin. The arginine-rich (ZR) and glutamic acid-rich 
(ZE) leucine zipper strands form stabilizing salt bridges between the arginine and 
glutamic acid residues located at positions e and g (Figure 2.1). Because of the 
exceptional affinity, the leucine zipper ZE/ZR has been utilized in the assembly of 
chimeric proteins for robust protein immobilization
50,51








Figure 2.1 The helical wheel diagram for the heptad repeats of ZE and ZR. 
 
 
2.1.2 Elastin-Like Polypeptides 
 Elastin-like polypeptides (ELPs) are artificial repetitive polypeptides derived from 
tropoelastin, which is predominantly found in the ECM.
53
 Commonly, ELPs consist of 
pentapeptide repeats of (VPGXG)n, where n is the number of repeats and X is a guest 
residue except proline. They undergo inverse phase transition from soluble to insoluble in 
aqueous phase when the temperature is elevated above the transition temperature (Tt).
54
 
The unordered conformation of ELP below Tt changes to β-turn above Tt.
55
 This behavior 
can be affected by composition and length of the repeats, ELP concentration, and ionic 
strength.
56
 Because of the attractive temperature-responsive properties, ELP-based 
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polypeptides have been extensively used for thermally triggered self-assembly of 




2.1.3 Random Coils 
 Random coils are polypeptide chains with no regular secondary structures. An 
artificial random coil developed in the lab is the alanylglycine-rich repeat (C10).
58
 The 
repetitive sequence is [(AG)3PEG]10, and it has been characterized to be water soluble 
and lack regular secondary structures. Although poly(glycylalanine) is arranged 
antiparallel β-sheets in solid, the odd number of residues in the repeat frustrates formation 
of secondary structures. C10 is a flexible polyelectrolyte segment and has been used to 
connect coiled coils in protein building blocks that form protein hydrogels.
59,60
 It retained 
water and prevented precipitation of the protein building blocks. 
 
2.2 Design of Recombinant Fusion Proteins 
 In this thesis, the hetero-dimeric leucine zippers ZE and ZR are the most important 
protein motifs used in design of recombinant protein building blocks. The rationale is that 
the strand ZE is combined with folded globular proteins so that fusion proteins containing 
ZE can be integrated with self-assembling proteins containing ZR to form suprastructures. 
In this concept, folded globular proteins are part of the protein building blocks and are 
incorporated into protein-based suprastructures. It is hypothesized that the extremely high 
affinity between ZE and ZR should be superior to any interactions between the folded 
globular proteins, offering a simple and robust strategy to integrate the chosen folded 
protein into suprastructures. That way, a modular and generalized platform can be 
realized, and it can incorporate a variety of biologically functional proteins including 




Figure 2.2 Recombinant fusion proteins. (A) ZR−ELP, (B) ZR−C10−ZR, (C) mCherry−ZE, 
(D) EGFP−ZE, (E) pRgpACAT−ZE (PDB ID: 2H5Q for mCherry, 1EMK for EGFP, and 
1CVR for RgpB which is a homolog to pRgpACAT). 
 
 
 Two proteins containing self-assembling domains were used to build protein 
suprastructures. First, a fusion protein of ZR and ELP (ZR−ELP
51
) was produced (Figure 
2.2A). The inverse phase transition of ELP can be exploited for temperature dependent 
protein self-assembly. It is a diblock co-polypeptide with molecular weight of 17 kDa, 
and combination of the two blocks in a single protein provides temperature-responsive 
amphiphilicity. Second, two identical strands of ZR were fused with the random coil 
fragment C10 to construct a triblock co-polypeptide, ZR−C10−ZR (19 kDa) (Figure 2.2B). 
Attractive interactions between side chains of C10 under controlled processes can drive 
self-assembly of the building blocks, and its flexibility can be exploited to fabricate 
protein-inorganic hybrid suprastructures. Detailed strategies for self-assembly of specific 
suprastructures are described in Chapter 3, 4, 5, and 6. 
 The counterpart building blocks, which carry folded globular protein domains for 





) were chosen. They are folded globular proteins that exhibit red and green 
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fluorescence, which are beneficial for characterization of the formed suprastructures and 
can be used for fundamental studies of their self-assembling characteristics. The glutamic 
acid-rich leucine zipper strand ZE was fused to the C-termini of either mCherry or EGFP 
in the form of diblock fusion proteins, mCherry−ZE or EGFP−ZE (34 kDa) (Figure 
2.2C,D). An affinity tag (His6) was inserted at the C-termini of the fusion proteins and 
used for purification. 
 In the same way, an enzyme was also fused to ZE. Particularly, the catalytic 
domain of a pathogenic cysteine protease RgpA was chosen as a potential therapeutic 
protein. Briefly, the protease RgpA is a virulence factor secreted from Porphyromonas 
gingivalis.
63
 It is an arginine-specific protease and has shown proteolytic activity toward 
the pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α).
64,65
 The proteolytic 
inactivation of TNF-α is a promising property of RgpA to suppress inflammatory 
responses. The propeptide and catalytic domain of RgpA (pRgpACAT) was selected from 
the full-length enzyme, and ZE was fused to the C-terminus of the catalytic domain to 
construct the fusion protein pRgpACAT−ZE (Figure 2.2E). The C-terminus of the fusion 
protein was also tagged with His6 for affinity chromatography. 
 Overall, two artificial self-assembling co-polypeptides and three fusion proteins 
containing folded globular protein domains were created and produced. Protein 
sequences for the five fusion proteins (ZR−ELP, ZR−C10−ZR, mCherry−ZE, EGFP−ZE, 
pRgpACAT−ZE) are provided in Appendix A. Characterizations of self-assembling 




2.3 Experimental Details 
2.3.1 Materials 
 Oligonucleotide primers were synthesized by Eurofins MWG Operon, and DNA 
polymerase (PfuUltra II Fusion HS) was purchased from Agilent Technologies. The E. 
coli strains XL1-Blue (Agilent Technologies) and AFIQ-BL21 were kind gifts from Prof. 
D. Tirrell at California Institute of Technology. The plasmids containing ZR−ELP, 
mCherry, and ZE fragments were also kindly provided by Profs. D. Tirrell and K. Zhang 
(University of Minnesota). The plasmid containing EGFP was a gift from Prof. A. 
Bommarius at Georgia Institute of Technology. The chromosomal DNA of P. gingivalis 
W50 was a gift from Dr. Joe Aduse-Opoku at Queen Mary University of London. The 
expression vector pQE60 (3.4 kbp) and nickel nitrilotriacetic acid (Ni-NTA) resin were 




 The gene fragment for ZR was PCR-amplified using primer pairs FZR1, RZR1 
and FZR2, RZR2 (see Appendix C for all primer sequences). In a single step, the two 
types of resulting fragments for ZR were ligated into the NcoI and BglII restriction sites of 
the pQE60 vector (3.4kbp). As a result, the plasmid pQE60-ZR−ZR was constructed. 
Next, the restriction site SalI was inserted to a gift plasmid from Profs. A. Sugawara-
Narutaki and D. Tirrell, by site-directed mutagenesis (SDM) using primers FSDM1 and 
RSDM1. Then, the C10 fragment was excised from the resulting plasmid by digestion 
using HindIII and SalI. The excised fragment was inserted between the two ZR fragments 
in pQE60-ZR−ZR, where the HindIII site at the end of the ZR−ZR fragment was removed 
by SDM using primers FSDM2 and RSDM2. Next, an additional DNA fragment, which 
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contains a ribosomal binding site (RBS) and the gene encoding His6ZE, was excised from 
the plasmid pQE60-His6ZE/ZR−ELP by digestion with EcoRI, and inserted into the EcoRI 
site of pQE60-ZR−C10−ZR plasmid. In the final step, a stop codon was inserted at the end 
of the gene encoding ZR−C10−ZR by SDM with primers FSDM3 and RSDM3. 
pQE60-mCherry−ZE 
 The two gene fragments encoding either mCherry or ZE were amplified by PCR 
using two pairs of primers FMF, RMF and FZE, RZE. The amplified fragments were 
assembled into a 0.9 kbp fragment that encodes mCherry-ZE via PCR-assembly, and 
amplified using primers FMF and RZE. The resulting PCR product was digested using a 
single restriction enzyme, BglII, and ligated into the BglII restriction site of pQE60 
(3.4kbp) vector. The sequence for C-terminal His6 tag is provided in pQE60 vector. 
pQE60-EGFP−ZE 
 In the first step, two gene fragments encoding either EGFP or ZE were amplified 
using two pairs of primers FEF, REF and FZE, RZE, respectively. In the second step, the 
amplified gene fragments were assembled by PCR-assembly, and amplified with primers 
FZE and RZE. The resulting DNA construct was digested and ligated into the BglII 
restriction site of the pQE60 vector. 
pQE60-pRgpACAT−ZE 
 The gene encoding pRgpACAT was amplified from the chromosomal DNA of P. 
gingivalis W50, using primers FRGP and RRGP. Using PCR-assembly technique, the 
amplified gene fragment was assembled with the ZE-encoding sequence that was PCR-
amplified using primers FZE and RZE. In the following step, the assembled fragment for 
pRgpACAT−ZE was amplified by PCR with primers FRGP and RZE. The 1.6 kbp 




ZR−ELP, ZR−C10−ZR, mCherry−ZE, and EGFP−ZE 
 Both ZR−ELP and ZR−C10−ZR were co-expressed with His6ZE to prevent 
degradation during expression.
51
 The co-expressed His6ZE forms protein complexes 
His6ZE/ZR−ELP or His6ZE/ZR−C10−ZR, which are resistant to proteolysis in the 
cytoplasm. All plasmids (pQE60-His6ZE/ZR−ELP, pQE60-His6ZE/ZR−C10−ZR, pQE60-
mCherry−ZE, and pQE60-EGFP−ZE) were transformed into E.coli strain AFIQ-BL21 for 
expression. All cell cultures were grown at 37°C in 2X yeast extract and tryptone (YT) 
media containing ampicillin (200 mg/L) and chloramphenicol (34 mg/L). When the cell 
culture optical density (OD) at 600 nm reached 0.8, protein expression was induced by 
1.0 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG). Cells were harvested by 
centrifugation after 5 hours of expression at 37°C. 
pRgpACAT−ZE 
 All plasmids pQE60-pRgpACAT−ZE was transformed into E.coli strain AFIQ-
BL21 for expression. Cell culture was grown at 37°C in 2X YT media containing 
ampicillin (200 mg/L) and chloramphenicol (34 mg/L). When the cell culture OD at 600 
nm reached 0.6, the temperature was decreased to 30°C. Then, protein expression was 
induced by 0.2 mM IPTG. Cells were harvested by centrifugation after 20 min of 
expression at 30°C. 
 
2.3.4 Purification 
 All recombinant fusion proteins were purified according to manufacturer 
instructions (Qiagen) except ZR−ELP and ZR−C10−ZR. Purified proteins were analyzed 
using tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). In 
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order to avoid hydrolysis during boiling, all protein samples were prepared by reducing 
proteins at room temperature for 30 min. 
ZR−ELP and ZR−C10−ZR 
 The harvested cells were centrifuged and resuspended in lysis buffer containing 8 
M urea, 10 mM Tris-Cl, and 100 mM Na2HPO4 (pH 8.0), and lysed by a cycle of 
freezing-thawing and ultrasonication. After centrifugation, the cleared cell lysate 
containing complexes either His6ZE/ZR−ELP or His6ZE/ZR−C10−ZR was incubated with 
Ni-NTA resin. After washing at pH 6.3, either ZR−ELP or ZR−C10−ZR was collected from 
elution buffer containing 6 M guadinine hydrochloride, 10 mM Tris-Cl, and 100 mM 
Na2HPO4 (pH 8.0). The elution buffer isolated either ZR−ELP or ZR−C10−ZR from the 
complexes bound to the NTA resin. Purified proteins were dialyzed into deionized water. 
mCherry−ZE 
 According to manufacturer instructions, mCherry−ZE was purified under the 
denaturing condition. All buffers contained 8 M urea, 10 mM Tris-Cl, and 100 mM 
Na2HPO4 and were adjusted to different pH values. Harvested cells were frozen, thawed, 
and sonicated in buffer at pH 8.0, and the cell lysate was cleared by centrifugation. The 
cleared cell lysate was incubated with Ni-NTA resin. After washing at pH 6.3, the protein 
was eluted from the resin at pH 4.5. After dialysis into phosphate buffered saline (PBS, 
pH 7.4), aggregates of insoluble protein were removed by centrifugation. 
EGFP−ZE and pRgpACAT−ZE 
 According to manufacturer’s instructions, either EGFP−ZE or pRgpACAT−ZE was 
purified under native conditions. All prepared buffers contained 50 mM Na2HPO4, 300 
mM NaCl, and 10 − 250 mM imidazole at pH 8.0. After cell lysis by freeze-thaw and 
sonication, the cleared cell lysate in buffer containing 10 mM imidazole was incubated 
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with Ni-NTA, washed (20 mM imidazole), and eluted in the presence of 250 mM 
imidazole. The eluted solution was dialyzed into PBS (pH 7.4). 
 
2.4 Results and Discussion 
 The Coomassie-stained SDS-PAGE images confirmed successful expression and 
purification of the fusion proteins. As observed in Figure 2.3A, the diblock and triblock 
co-polypeptides ZR−ELP (17 kDa) and ZR−C10−ZR (19 kDa) were purified. Although 
purified ZR−C10−ZR appears at higher molecular weight (34 kDa) than prediction, it is 
consistent with previous work on an artificial co-polypeptide containing two strands of 
ZR, which also runs at a higher molecular weight.
52
 I hypothesize that the two ZR strands 
connected by the linker chain C10 might dimerize even in the presence of SDS. It is 





The yields for ZR−ELP and ZR−C10−ZR from 1L culture were approximately 200 mg and 
45 mg, respectively. Expression and purification of the fusion proteins containing 
fluorescent proteins (mCherry−ZE and EGFP−ZE) was also analyzed using SDS-PAGE 
(Figure 2.3). Since the N=C bond of the chromophore of mCherry is hydrolyzed by 
boiling commonly performed during sample preparation,
66
 unboiled mCherry−ZE was 
analyzed. The fusion protein mCherry−ZE (34 kDa) was very resistant to denaturation by 
SDS and urea, especially without boiling, showing fluorescence even in the gel. 
Therefore, the gel also contains partially folded mCherry−ZE proteins, which exhibit 
different mobilities, but are still fluorescent (~45 kDa and ~30 kDa). EGFP−ZE also 
appeared as the fully folded fraction (34 kDa) and partially folded fraction (slightly 
below 34 kDa) in the SDS-PAGE gel. Fluorescence from those protein bands confirmed 
that they are from either mCherry−ZE or EGFP−ZE, not impurities (Figure 2.3B,C). 
 Cysteine proteases are expressed as zymogens, which are combined with 
propeptide domains.
67







Figure 2.3 SDS-PAGE gel images from Coomassie Blue staining (A) and fluorescence 
of mCherry−ZE (B) and EGFP−ZE (C): ZR−ELP (lane 1), mCherry−ZE (lane 2), 
EGFP−ZE (lane 3), ZR−C10−ZR (lane 4), and pRgpACAT−ZE (lane 5). Arrows in lane 5 
indicate full-length (i), partially cleaved (ii), and fully cleaved pRgpACAT−ZE (iii), 
respectively. Fluorescence from the protein bands was imaged at filter settings of 





N-terminal peptides. The propeptide domain of RgpA is also critical for folding of 
RgpA.
63
 The full length 84 kDa pRgpACAT−ZE zymogen was purified. The intermediate 
with partially cleaved propeptide (72 kDa) and the mature enzyme with full cleavage of 
propetide (60 kDa) were also observed by SDS-PAGE (Figure 2.3A). The cleavage of the 
propeptide domain is known to be autolytically processed.
63
 Thus, observation of the 
autolytic cleavage of the propeptide domain confirms that the purified pRgpACAT−ZE is 
properly folded with retained proteolytic activity. 
 
2.5 Conclusion 
 In this chapter, biosynthesis of recombinant fusion proteins was demonstrated. 
Two artificial self-assembling co-polypeptides (ZR−ELP, ZR−C10−ZR) and three fusion 
proteins that carry folded globular protein domains (mCherry−ZE, EGFP−ZE, 
pRgpACAT−ZE) were designed and produced. Proteolytic degradation of proteins 
containing ZR was prevented by co-expression of His6ZE. The folded globular proteins 
were fused with ZE using PCR-assembly, and the observed activities of mCherry, EGFP, 










 Therapeutic proteins require controlled delivery to the target tissue to maintain the 
local concentration over a prolonged period of time. A common approach is to delay 
protein release with a hydrogel matrix, which provides affinity interactions or diffusive 
barriers.
68
 Physical entrapment of proteins in a matrix allows sustained release due to free 
volume, hydrodynamic drag, and obstruction effects.
69
 Affinity-based approaches exploit 
specific binding interactions between natural
70
 or engineered binding ligands
71
 attached 
to the hydrogel matrix and therapeutic proteins. However, hydrogel-based approaches 
inherently involve relatively large amounts of carrier material compared to the entrapped 
protein therapeutic. Toxicity concerns may arise from synthetic crosslinkers or initiators 
used in polymerization,
40,72
 or modification of biological polymers.
73
 Biocompatibility 
issues, such as the foreign body response, may be present at the interface between tissue 
and materials.
41
 Thus, a strategy that uses no or a minimal amount of carrier material is 
ideal, to eliminate these challenges. Herein, we demonstrate that the concept of “carrier-
free” can be realized by adopting a different physical principle, protein self-assembly. 





 While much effort has been focused on fabrication of self-
assembled matrices,
60,74-77







 are modulated by protein self-assembly. In 




 Reproduced with permission from Park, W. M. and Champion, J. A. Angew. Chem. Int. Ed. 2013, 52, 
8098–8101. Copyright 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
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this study, we describe a self-assembly system in which proteins self-control their 
molecular transport in a model extracellular matrix (ECM). Engineered protein building 
blocks spontaneously self-assemble into particles in the ECM, become trapped, and 
dissociate to be released at a controlled rate. This protein self-assembly is mediated by 
temperature-responsive coacervation and dissociation, and by specific binding of high-
affinity protein motifs under physiological conditions. Since the ECM selectively 
regulates microscopic motion of objects depending on their size,
80
 the diffusion of protein 
building blocks is modulated as they form particles under non-equilibrium conditions. 
 




 was purchased from BD Bioscience. PBS (1X, pH 7.4) containing 
NaCl (137 mM), KCl (2.7 mM), Na2HPO4 (10 mM), KH2PO4 (1.8 mM) was prepared in 
the lab. 
 
3.2.2 Characterization of Inverse Phase Transition 
 Aqueous solutions of ZR–ELP at various concentrations (1, 2, 4, 8, 16, 32 μM) 
were prepared in PBS (pH 7.4). The OD of the samples at 350 nm was obtained using a 
UV/vis spectrophotometer (Beckman Coulter) while the temperature increased at a rate 
of 1 °C/min. The transition temperature (Tt), at which dOD/dT is maximized, was 
estimated from the turbidity profiles. 
 Kinetics of the inverse phase transition was also analyzed by measuring the 
turbidity profile over time. Three concentrations, at which the transition occurs with a 
temperature elevation from 25 °C to 37 °C, were chosen, and OD at 350 nm was recorded 
for 15 min. A mathematical model,
81
 which has been used for coacervation of 
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      (3.1) 
where OD is a function of the concentration proportionality factors (a, b), the baseline 
(c), and the rate constant for maturation (km). The turbidity profiles at three different 
concentrations of ZR–ELP (4, 8, 16 μM) were fitted to the mathematical model. 
 The rate constant for coacervation (kc) was estimated at various temperatures (24, 
28, 31, 34, 36, 40 °C) and the calculated values for ln(kc) were plotted as a function of 
1/T. The Arrhenius model was used to calculate activation energy (Ea). 
 
3.2.3 Estimation of Binding Kinetics 
 An aqueous solution of ZR–ELP (8 μM in PBS) was incubated at 37 °C for 20 
min. The solution became turbid, and 2 μL of the sample was placed on the pre-warmed 
glass substrate in a temperature controlled incubation chamber at 37 °C. After addition of 
mCherry–ZE at different concentrations (0.04, 0.2, 1 μM), the coacervated ZR–ELP 
particles were monitored for 2 min using a fluorescence microscope (Axio Observer.Z1, 
Carl Zeiss) with a 100X objective (excitation: 565/30 nm, emission: 620/60 nm). The 
fluorescence intensity profiles were quantified as a function of incubation time, and fitted 
to a bimolecular binding model
82














max     (3.2) 
where I(t) is the fluorescence intensity, Imax is the maximum intensity at saturation, C0 is 
the initial concentration of mCherry–ZE, and kon and koff are the rate constants for 
association and dissociation, respectively. 
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3.2.4 Preparation of Matrigel Film and Analysis of Self-Assembly 
 Matrigel
TM
 was cast as a thin film (5 mm × 5 mm × 0.5 mm) by loading the 
solution into a mold of two polycarbonate plates. Matrigel solution (15 μL) was pre-
warmed at 37 °C for 5 min, loaded in the mold, and warmed at 37 °C for 5 min. In order 
to prevent drying at the interface, the Matrigel film was further allowed to gelate while 
covered with pre-warmed PBS for 10 min. The top plate was removed, and 5 μL of ZR–
ELP (8 μM) solution was placed as a thin layer on the top of the Matrigel film. After 
incubation for 20 min, a solution of mCherry–ZE was added at a concentration of 1 μM 
for an incubation of 10 min. The Matrigel film was then washed with pre-warmed PBS 
for 1 min before imaging. The resulting self-assembled particles in Matrigel were imaged 
using a fluorescence microscope with a 100X objective. While imaging, the Matrigel film 
samples were placed in an incubation chamber that maintained temperature at 37 °C. The 
images of individual particles at different depths were also taken from the Matrigel films 
using a 100X objective in order to demonstrate inhomogeneity of particle density along 
the depth. The changes in particle size and fluorescence intensity over time were also 
characterized by imaging samples in 100 μL of PBS at 37 °C for 0.5, 12, and 24 hours. 
We validated the method of particle sizing from micrographs by comparing size 
distributions of particles in PBS obtained with dynamic light scattering (DLS). In a 
control experiment, formation of particles was investigated when ZR-ELP and Matrigel 
solution were pre-mixed at 4 °C, warmed up to 37 °C, and followed by addition of 
mCherry–ZE to the formed Matrigel matrix. For scanning electron microscope (SEM) 
imaging, the samples were fixed with glutaraldehyde (1.0 %) for 2 hours. After washing 
with deionized water for 30 min, the fixed samples were freeze-dried. The samples were 
sputter-coated with gold, and imaged with Zeiss Ultra60 FE-SEM at 5 kV. A sample of 
Matrigel treated with only PBS was also imaged as a control. 
 For the study on the particle layer formation, the narrow side of Matrigel film 
between polycarbonate plates was exposed to solutions of ZR–ELP (4, 8, 16 μM) and 
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mCherry–ZE (1 μM) in series as described above. The interface region between solution 
and Matrigel phase was imaged, and the averaged intensity profiles of the fluorescence 
layer, where the self-assembled particles formed, were quantified from the images 
obtained using a 10X objective. 
 
3.2.5 Determination of Diffusivities 
 Diffusivity of mCherry–ZE was determined by obtaining fluorescence intensity 
profiles in Matrigel. A solution of mCherry–ZE (1 μM) was placed at the narrow side of a 
thin Matrigel film (5 mm × 5 mm × 0.5 mm), and the fluorescence intensity profiles were 
obtained as a function of time. The intensities at different time and positions were fitted 














        (3.3) 
 C = 0   for  0 < x < l,  t = 0    (3.4a) 
 C = C1(t)  for  x = 0,   t > 0    (3.4b) 
 C = C2(t) for  x = l,   t > 0    (3.4c) 
where C is the concentration of mCherry–ZE, which is proportional to fluorescence 
intensity, and D is the diffusivity. The initial and boundary conditions are provided in 
Equation 3.4. The interface between the solution and Matrigel is defined as the 
coordinate where x = 0, and l is the length of the Matrigel film. Since the length, l, was 
long enough so that mCherry–ZE molecules could not reach to the end, C2(t) remained 
zero during the experiment. From the boundary conditions, an analytical solution is 




















      (3.5) 
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The average fluorescence profiles were fitted to determine the diffusivity of mCherry–ZE 
using least square method. 
 The diffusivity of the self-assembled mCherry–ZE/ZR–ELP particles was 
determined either in Matrigel or solution phase by tracking trajectories of particles’ 
positions. The particles were prepared in Matrigel or in PBS as described in the previous 
section, and fluorescence and differential interference contrast (DIC) images were 
obtained using a microscope (100X). Imaging was performed for 6 s at a rate of 11.3 
frames/s, and the time-dependent positions were acquired by tracking the particles in the 
images using AxioVision particle tracking software. The mean-square displacement 
(MSD) was calculated from the pseudo two-dimensional trajectory of the particles. The 















      (3.6) 
where r is a position vector for a particle at time t, and τ is lag time. Diffusivity follows 
the relation MSD(τ) = 4Dτ for the pseudo two-dimensional motion of particles in 
Matrigel.
84
 Thus, we could calculate the diffusivity for the particles from the slopes in the 
plot of MSD vs. lag time (τ). 
 
3.2.6 Circular Dichroism Spectroscopy 
 The circular dichroism (CD) spectra for proteins at different states of self-
assembly in solution phase (PBS, pH 7.4) were recorded on a Jasco J-810 spectrometer. 
ZR–ELP and self-assembled mCherry–ZE/ZR–ELP particles were prepared in PBS (pH 
7.4). The measurements were performed in a 0.5-cm-length cuvette, and the average 
spectra of five measurements were obtained from a wavelength range of 200 – 300 nm 
with 1 nm increments. The unit for mean residue ellipticity was converted with respect to 
total protein concentration and average number of amino acid residues. Estimation of 
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secondary structure content was performed with CDSSTR program provided in CDPro 
software package. 
 
3.2.7 Estimation of Protein Retention in the ECM 
 Protein retention in the ECM was estimated by quantifying release of the model 
therapeutic protein, mCherry–ZE, from Matrigel. A thin Matrigel film (30 μL, 1.5 mm 
thick) was cast on the bottom of cylindrical tube, where mCherry–ZE and ZR–ELP were 
assembled as particles at the bottom surface. The film was covered with 150 μL of pre-
warmed PBS (pH 7.4), and incubated at 37°C. The release buffer solution was sampled at 
1, 2, 4, 8, 16, 24, 48, 72, 96 hours and replaced with fresh buffer solution. The 
concentration of mCherry in the samples was quantified by measuring fluorescence 
intensity (excitation: 585/9.0 nm, emission: 610/13.5 nm) using a microplate reader. The 
intensity of each sample was converted to concentration by a calibration curve, and the 
remaining amount of mCherry in the Matrigel was calculated. The experiment was 
performed in triplicate, and the control experiment was conducted with same amount of 
mCherry–ZE without ZR–ELP. 
 
3.3 Modeling Details 
 Formation of particles in the ECM follows a reaction-diffusion model, which is 
based on gel-phase diffusion of dispersed monomeric ZR–ELP, its coacervation, diffusion 












































































       (3.7d) 
where concentration, Ci, diffusivity, Di, and reaction terms, Ri, were included in the 
model. The subscript i denotes the component in the self-assembly system (e: monomeric 
dispersed ZR–ELP, c: coacervates of ZR–ELP, m: monomeric dispersed mCherry–ZE, p: 
the self-assembled mCherry–ZE/ZR–ELP particles). Since the determined diffusivity of 
mCherry–ZE was in agreement with an empirical correlation for diffusivity as a function 
of hydrodynamic radius of macromolecules,
83
 the diffusivity of monomeric ZR–ELP 
(hydrodynamic diameter, dH ≈ 4.7 nm) was calculated to be 96.1 µm
2
/s from the 
correlation. As the coacervation kinetics was estimated to be a first order reaction, the 
reaction terms for coacervation were expressed as Rc = – Re = kcCe. The affinity binding 
of mCherry–ZE was expressed as Rp = – Rm = konCmCc – koff Cp where kon and koff are the 
association and dissociation rate constants, respectively. Also, coacervation of ZR–ELP 
was modeled to occur only above the minimal concentration of ZR–ELP at 37 °C (~ 1.9 
µM). The initial and boundary conditions are: 
 1. The first step (coacervation) 
 Ce = Ce,b    for  x = 0,   t = 0  (3.8a) 
 Ce = 0     for  0 < x ≤ l, t = 0  (3.8b) 
















































C ce    for  x = l,   t > 0  (3.8f) 
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 2. The second step (affinity-binding) 
 Ce = Ce0(x)    for  0 ≤ x ≤ l,  t = 0  (3.9a) 
 Cc = Cc0(x)    for  0 ≤ x ≤ l,  t = 0  (3.9b) 
 Cm = Cm,b    for  x = 0,   t = 0  (3.9c) 
 Cm = 0    for  0 < x ≤ l, t = 0  (3.9d) 

































































































C pmce   for  x = l,   t > 0  (3.9j) 
where the concentrations in the bulk solution phase are indicated as Ci,b. The diffusivities 
l
iD  in the solution phase were estimated from the experiments or the Stokes-Einstein 
equation.
85
 The boundary conditions account for our experimental observations that the 
diffusive fluxes from the solution phase equal the fluxes that enter the Matrigel phase and 
that the partition coefficient is close to unity, as described above. Ce,b was assumed to 
follow coacervation kinetics ( )exp(0,, tkCC cbebe  ) as coacervation simultaneously occurs in 
both solution and Matrigel phases. In order to reflect the discrepancy during initial 
kinetics, coacervation was implemented to have a concentration dependent lag time (τc = 
– 0.7213lnCe + 2, correlated from the coacervation kinetics). For three values of the 
initial concentration of ZR–ELP ( 0,beC ) in the solution phase (4, 8, 16 µM), the distribution 
of self-assembled particles in Matrigel was predicted using Matlab. From the first step 
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(coacervation), the concentration profiles of monomeric (Ce0(x)) and coacervates of ZR–




3.4.1 Two-Step Protein Self-Assembly in the ECM 
 The system is built from two different diblock fusion proteins. The first 
component (mCherry–ZE) is constructed from a globular fluorescent protein mCherry,
61
 
which serves as a model for a therapeutic protein, and a glutamic acid-rich leucine zipper 
(ZE). An arginine-rich leucine zipper (ZR) and elastin-like polypeptide (ELP) comprise 
the second component (ZR–ELP)
51
 (Figure 3.1A). ELP is composed of a pentapeptide 
repeat derived from tropoelastin, which undergoes a temperature-responsive inverse 
phase transition from soluble to coacervate phase.
54
 The leucine zipper motifs ZE and ZR 





The fusion proteins were produced separately via bacterial protein synthesis and 
purified.
51
 In aqueous solution, ZR–ELP showed the expected inverse phase transition as 
characterized by an increase in light scattering upon temperature elevation (Figure 3.1B 
and Figure 3.2). The transition temperature is dependent on the concentration of ZR–ELP 
in PBS (pH 7.4), and ZR–ELP at 1.9 to 24 μM formed coacervates when the solution was 
heated from 25 to 37 °C. Subsequent addition of mCherry–ZE resulted in rapid binding to 
the ZR-ELP coacervates within a minute (Figure 3.3), showing an association rate 






 (Figure 3.1C). As elucidated by kinetic analysis (Figure 
3.2) and circular dichroism (Figure 3.4 and Table 3.1), ZR/ZR coiled-coils of ZR–ELP 
simultaneously unfold during the phase transition followed by subsequent refolding of 
ZR/ZE heterodimer coiled-coils upon binding of mCherry–ZE. 
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Figure 3.1 Protein building blocks and their self-assembly in solution phase and in ECM. 
(A) The recombinant engineered protein building blocks, mCherry–ZE and ZR–ELP, are 
produced separately, but self-assemble via formation of coiled-coils (PDB ID: 2H5Q for 
mCherry). (B) The inverse phase transition of ZR–ELP in aqueous solution: Temperature 
vs. optical density (OD at λ = 350 nm) measured at different concentrations of ZR–ELP 
(1, 2, 4, 8, 16, 32 μM). (C) The binding kinetics estimated by fluorescence intensity 
changes of the ZR–ELP coacervates upon incubation with mCherry–ZE (0.04, 0.2, 1 μM). 
The measured intensities (dots) were fitted to a bimolecular binding model (lines). (D) 






Figure 3.2 Kinetics of the inverse phase transition of ZR–ELP. (A) The turbidity profile 
of ZR–ELP (4, 8, 16 μM) in PBS (pH 7.4) as temperature increases from 25 °C to 37 °C: 
the turbidity profile was measured at 350 nm (open circles) and fitted to the mathematical 
model (Equation 3.1) (solid lines) to estimate kc. As a result, kc was estimated to be 0.70 
± 0.12 min
– 1




): activation energy for 
coacervation was calculated from the fitted linear slopes (solid lines). The slope of ln (kc) 
vs. 1/T showed two different values depending on temperature. In the lower temperature 
region (24 to 30 °C), Ea was calculated as 23.7 kcal mol
–1
, whereas a negative value (– 
25.2 kcal mol
–1
) was obtained for the higher temperature region (30 to 40 °C). The 
negative Ea indicates that coacervation of ZR–ELP does not have an energy barrier and kc 
decreases with increasing temperature. We hypothesize that ZR/ZR homodimers start to 
unfold and deform above 30 °C so that the reaction rate for coacervation becomes slower 





Figure 3.3 Affinity binding of mCherry–ZE to ZR–ELP coacervates. (A) Fluorescence 
micrographs of mCherry–ZE/ZR–ELP particles in solution phase. (B) The changes in the 





Figure 3.4 The changes in secondary structure of the protein building blocks. The CD 
spectra of dispersed monomeric (25 °C, black) and coacervated ZR–ELP (37 °C, gray), 
and the self-assembled mCherry–ZE/ZR–ELP particles (37 °C, pink). 8 µM of ZR–ELP 




Table 3.1 The secondary structure of the protein building blocks analyzed from the CD 
spectra (Figure 3.4). Comparison of calculated and experimental results is provided in 












ZR-ELP (25°C)  29.4 / 0.0 35.1 13.5 52.2 0.036 
ZR-ELP (37°C) 29.4 / 0.0 2.0 38.5 57.9 0.322 
SA mCherry-ZE/ZR-ELP 
Particles (37°C) 
27.8 / 1.6 7.0 36.2 56.0 0.108 
 
 
 Next, we performed the two-step self-assembly of the fusion protein components 
in the ECM as illustrated in Figure 3.1D, using a reconstituted ECM hydrogel 
(Matrigel
TM
) as a model for the native ECM. The inverse phase transition of soluble ZR–
ELP (25°C) that permeated through the ECM hydrogel (37°C) resulted in the in situ 
formation of coacervated particles. In the second step, mCherry–ZE was added and bound 
to the particles via the high-affinity interaction between the leucine zipper motifs. As a 
result, we observed formation of fluorescent particulates of mCherry–ZE/ZR–ELP in the 
ECM hydrogel (Figure 3.5A,B and Figure 3.6A) with diameters ranging from 330 nm to 
1.6 μm. Interestingly, we found particulates with irregular shapes that seemed to be from 
incomplete coalescence of coacervated ZR–ELP nanoparticles (Figure 3.5C). In aqueous 
solution, ZR–ELP grows into microspheres with smooth surfaces by the coacervation-
coalescence process, and the binding of mCherry–ZE does not influence the surface 
morphology (Figure 3.3). Therefore, the observation of non-spherical particles in the 
ECM hydrogel indicates that the coalescence of the coacervates is limited by the presence 
of the matrix. When ZR–ELP was premixed with ECM solution at 4 °C and warmed up, it 











Figure 3.5 The mCherry–ZE/ZR–ELP particles that self-assembled in ECM hydrogel. (A) 
Fluorescence micrographs of particles formed in Matrigel (inset scale bar 1 μm) (B, C) 
Scanning electron micrographs of the particles (arrowed): the particle-embedded Matrigel 
was fixed with glutaraldehyde for 2 hr, and freeze-dried. For comparison, the Matrigel 
treated with only PBS was imaged (inset in (B), scale bar 5 μm, insets in (C), scale bars 
500 nm). (D) Diffusivity (D) of mCherry–ZE (mChZ) and self-assembled particles 








Figure 3.6 Characterization of mCherry–ZE/ZR–ELP particles (A) Particles at different 
depths: Z = 0 μm (near the interface), 14.1 μm, and 72.9 μm. (B) Comparison of size 
distributions of the particles in PBS obtained from micrographs (bars) and DLS (line). 
(C) Morphology of mCherry–ZE/ZR–ELP particles from premixing of ZR–ELP and 
Matrigel solution at 4°C: The mixed solution was warmed up to 37°C and mCherry–ZE 





Figure 3.7 Determination of diffusivities for mCherry–ZE and self-assembled mCherry–
ZE/ZR–ELP particles. (A) The fluorescence intensity gradient of mCherry–ZE in Matrigel 
(points) was fitted to a Fickian diffusion model (solid line) to estimate the diffusivity, D. 
(B) MSD was plotted as a function of lag time for the self-assembled particles in Matrigel 
(red) and in PBS (black). 
 
 
the matrix (Figure 3.6C). Hindered by the matrix, the self-assembled mCherry–ZE/ZR–
ELP particles formed in the ECM hydrogel showed reduced diffusivity. Estimated from 
particle trajectories, the diffusivity of mCherry–ZE/ZR–ELP particles was 2.5 fold lower 
in the ECM hydrogel than in aqueous solution, and 500 fold lower than that of 
monomeric mCherry–ZE in the ECM hydrogel (Figure 3.5D and Figure 3.7). Indeed, the 
in situ self-assembly resulted in entrapment of the model protein, mCherry, in the ECM 
hydrogel by the self-assembly process. The low diffusivity of the self-assembled 
mCherry–ZE/ZR–ELP particles is based on the hydrodynamic and steric interactions of 
the particles with the ECM,
86
 and their insignificant electrostatic interactions with the 
matrix (zeta potential, ζ ≈ –2.6 mV)
84
 allow the protein particles to be locally dynamic at 
a reduced mobility rather than immobilized on the matrix. 
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3.4.2 Self-assembled Particle Layer 
 Estimated using a mathematical model,
81
 the coacervation by inverse phase 
transition of ZR–ELP has a rate constant, kc ≈ 0.7 min
–1
 (Figure 3.2A). The characteristic 
time for coacervation, τc (≈ 1/kc) is ≈ 90 s. The characteristic length for the system L (≈ 
(D/kc)
–0.5
) is approximated as 100 μm if τc is on the same order with the characteristic 
time for the diffusion of dispersed ZR–ELP, τd (≈ L
2
/D). Thus, the scaling analysis 
accounts for the simultaneous diffusion and temperature-responsive coacervation of ZR-
ELP in the ECM. This is a reaction-diffusion system, which allows formation of self-
assembled particles in a layer of thickness, L. The coacervated ZR–ELP particles 
accumulated in the layer and mCherry–ZE rapidly bound to the particles during the 
second step of self-assembly. We observed formation of a fluorescent layer near the ECM 
hydrogel-solution interface in Figure 3.8, and the initial concentration of ZR–ELP 
controlled the amount of particles in the layer, as indicated in the fluorescence images 
(Figure 3.8B). The diffusion, coacervation, and affinity-binding of the protein building 
blocks in the ECM hydrogel were modeled by a one dimensional reaction-diffusion 



















      
(3.10) 
where x is distance from the solution-hydrogel interface, Ci is concentration, Di is 
diffusivity, and Ri is the reaction term for a protein or particle component i. In our model, 
coacervation of ZR–ELP from soluble proteins to particles was included in the reaction 
term, and the diffusivity of the particles was assumed to be constant since their size does 
not change significantly once they form. The modeling results were consistent with the 
experimental results (Figure 3.8C), supporting the theoretical argument of in situ self-
assembly in the ECM hydrogel. Although the model does not duplicate the experimental 
mCherry fluorescence profile exactly, it demonstrates the ability to control the amount of 




Figure 3.8 The layer of self-assembled particles in ECM hydrogel. (A) Schematic 
illustration of the model system. (B) Fluorescence micrographs of the layer where 
particles are located. (C) The corresponding profiles of fluorescence intensity at distance 
(L) from Matrigel-solution interface: the experimental results of averaged profiles (solid) 
were compared with the profiles from modelling (dashed). The initial concentration of 
ZR–ELP was varied (4, 8, 16 μM), and the computational modelling was performed based 
on reaction-diffusion equations. 
 
 
3.4.3 Dissociation of Self-Assembled Particles 
 The self-assembled mCherry–ZE/ZR–ELP particles in the ECM hydrogel are 
metastable, and ZR–ELP dissociates from the particles when the local concentration of 
ZR–ELP drops below the minimum phase transition concentration (~ 1.9 μM at 37°C).  
As a result, the in situ self-assembled particles shrank over time in the ECM hydrogel. 
The average diameter (d) decreased from 828 ± 354 nm to 542 ± 158 nm during the first 
24 hours (Figure 3.9A). The size distribution of the particles also narrowed, indicating 
that the particles larger than 1 µm shrank more rapidly. The surface erosion from larger 
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particles (d > ~ 1 μm) is faster than smaller particles due to the ouzo effect that smaller 
particles are thermodynamically favored when the concentration of ZR–ELP decreases.
87
 
Concurrently, the fluorescence intensity of the particles was reduced by half after 12 
hours of dissociation proceeded, and there was further reduction in fluorescence to 37.8% 
of the initial value after 24 hours (Figure 3.9B). The initial drop in intensity is attributed 
to the rapid shrinking of the large particles (d > 1 µm), when the rate of decrease in 
intensity is proportional to the shrinking rate of the particles. While the average size of 
particles gradually decreased, the approximate concentration of mCherry on the particles 
remains approximately constant after an initial decrease of 40.6% in the first 12 hours 
(calculated from the fluorescence intensity per unit area of particles). It indicates that 
dissociation of ZR–ELP from the particles seems to also induce release of mCherry–
ZE/ZR–ELP. 
 As suggested by the dissociation kinetics of particles, self-assembly resulted in an 
enhanced retention of proteins in the ECM hydrogel (Figure 3.9C). The in situ assembled 
protein building blocks in the ECM hydrogel were exposed to a reservoir of 37 °C PBS to 
simulate the ECM environment in vivo and generate a concentration sink to induce 
disassembly and diffusion. The overall retention of mCherry–ZE with ZR–ELP was 
enhanced by 100% compared to monomeric mCherry–ZE, of which less than 30% 
remained in the ECM hydrogel after 24 hours. Consistent with the observed dissociation 
kinetics in Figure 3.9B, dissociation of mCherry–ZE from the self-assembled particles led 
to an initial clearance of mCherry–ZE (~ 36 % loss over 12 hours), which was much 
slower than soluble mCherry–ZE (~ 58 % loss). Considering the drastic difference in 
diffusivities of soluble proteins and particles (~ 500 folds), the controlled release of 
mCherry–ZE in the ECM hydrogel should have resulted from dissociation of mCherry–ZE 
from the particles. Furthermore, when mCherry without the ZE domain, was added 
together with ZR–ELP in the ECM hydrogel, the release profile of mCherry/ZR–ELP was 
very close to that of mCherry–ZE alone. This result indicates that mCherry does not have 
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specific interactions with ZR–ELP and that the coacervates do not alter the release 





Figure 3.9 Dissociation of mCherry–ZE/ZR–ELP particles. (A) Particle size distribution 
changes with time: the frequency of particles is indicated for corresponding diameter, d. 
(B) Fluorescence intensity changes upon particle dissociation: the overall average 
intensity (black) and the intensity per unit area of the particles (blue). (C) The release of 
mCherry- ZE imbedded in Matrigel as a soluble protein (black, mCherry–ZE) or self-







 Compared to the conventional recombinant conjugation of therapeutic protein 
directly to ELP, the two-component system based on the leucine zippers (ZR/ZE) shows 
new features in the inverse phase transition behavior of ELP. ELP–peptide or ELP–
protein conjugates have been engineered to self-assemble into nanoparticles upon the 
inverse phase transition,
88-90
 which has led to remarkable progress in delivery of chemo-
38,91
 and protein therapeutics.
92,93
 While ELPs of more than 60 repeats of the pentapeptide 
exhibit less concentration dependence, ZR–ELP (25 repeats) undergoes inverse phase 
transition at relatively low temperatures (40 to 20°C) with a strong concentration 
dependence (1 to 100 μM). This allows self-assembly and disassembly due to 
concentration gradients at 37°C. Also, the ratio of functional protein to ELP is very 
flexible as they can be conjugated at different molar ratios after coacervation. 
 Our system is widely applicable for local delivery of protein therapeutics to 
diseased sites, where proteins could be topically applied or injected, and upon contact 
will warm to body temperature and start the assembly process. We note that this system 
has several advantages as a new strategy for protein delivery. First, carrier-free delivery 
based on protein self-assembly does not involve use of excessive synthetic or biological 
materials with potential biocompatibility or toxicity issues.
40,41,72,73
 The self-assembling 




 human proteins, and 
toxicity potential is decreased.
94,95
 Furthermore, ELP has been reported to stimulate 
granulation in wounds,
39
 which could have synergetic effects for protein delivery 
specifically in wound healing applications. Second, 100% of dosed protein is spatially 
distributed in the ECM, and the temporal concentration gradient resulted by the 







 In summary, we have described a protein self-assembly system where the protein 
components self-assemble in the ECM and become entrapped as particles, demonstrating 
potential as a new type of “carrier-free” protein delivery approach. Our analysis shows 
spontaneous diffusion-coacervation and high-affinity binding processes that mediate in 
situ formation of self-assembled particles that shrink and release protein in the ECM. 
Though demonstrated with a model fluorescent protein, this new concept is widely 










 Vesicles are enclosed compartments created by self-assembled membranes of 
amphiphiles. While biological vesicles made from amphiphilic small molecules, 
predominantly phospholipids, are abundant in nature, their macromolecular analogues 
have been developed primarily using synthetic block copolymers.
97
 Polymeric vesicles 
exhibit enhanced stability and mechanical properties,
98







 can be tuned. Besides synthetic block copolymers, biological copolymers 
such as polypeptides
102,103
 and recombinant proteins
104
 have also been developed to self-
assemble into vesicles. They are biocompatible and biodegradable and can offer 
biofunctionality through incorporation of peptide sequences or folded proteins. Self-
assembly of folded proteins, in many examples, provides a versatile method to fabricate 
functional biomaterials for a range of applications.
22,105
 However, direct incorporation of 
folded and biologically relevant moieties into protein amphiphiles can prevent 
conformational arrangement of chains during vesicle formation, and their molecular 
weight might be limited. Furthermore, organic solvents, which are typically added to 
dissolve amphiphilic proteins or polypeptides,
102,104
 can hamper biological activity of 
incorporated folded proteins. For these reasons, vesicles of folded recombinant proteins 
are underdeveloped.
104
 In fact, folded, globular proteins have been incorporated into 




 Reproduced with permission from Park, W. M. and Champion, J. A. J. Am. Chem. Soc. 2014, 136, 
17906–17909. Copyright 2014 American Chemical Society." 
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vesicles only as hybrid forms of protein-synthetic polymers.
106
 Herein, we report self-
assembly of vesicles from recombinant protein amphiphiles that contain folded globular 
proteins. In aqueous solution, formation of hollow vesicles with globular proteins results 
from temperature-responsive phase transition. Depending on the conditions, vesicles can 
encapsulate protein coacervates formed simultaneously. In addition, small molecules and 
nanoparticles can preferentially be encapsulated in the vesicles. 
 An elastin-like polypeptide (ELP) motif serves as the hydrophobic block. It is a 
penta-repeat polypeptide derived from tropoelastin that undergoes an inverse phase 
transition, from soluble to insoluble, in aqueous solution as temperature increases above 
the transition temperature.
54
 It is an attractive process to construct various nanostructures 
via thermally triggered self-assembly. When combined with hydrophilic domains, 







 While random coil peptides were used as 
hydrophilic blocks in most examples, rigid, rod-shaped leucine zipper coiled coils and 
globular proteins are used here. Combined with an ELP, the folded proteins are 
incorporated into self-assembled vesicles as part of the building blocks. 
 
4.2 Experimental Details 
4.2.1 Materials 
 Fluorescent polystyrene nanoparticles (Fluoresbrite® YG Carboxylate 





4.2.2 Self-Assembly of Vesicles and Encapsulation 
 Solutions of the purified recombinant proteins, ZR−ELP, mCherry−ZE, and 
EGFP−ZE were mixed on ice. The final protein and salt concentration was adjusted by 
adding deionized water and diluting concentrated buffer (100 mM Na2HPO4, 18 mM 
KH2PO4, 27 mM KCl, and 1.37 M NaCl, pH 7.4). The protein mixture solutions were left 
on ice for 15 min. Next, the solutions were placed at room temperature (25 °C) for 1 hour 
to form vesicles. Encapsulation was performed following the same procedure as vesicle 
self-assembly, except that 50 μg/mL of fluorescein or 125 μg/mL of fluorescent 
polystyrene nanoparticles (1.8 X 10
9
 particles/mL) were added to protein mixture 
solutions on ice before room temperature incubation.  
 
4.2.3 Confocal Microscopy 
 Confocal micrographs were obtained with a Zeiss LSM 510Vis (Carl Zeiss). A 
droplet of vesicle samples (5 μL) was placed on a rectangular glass (24 x 60 mm), which 
was covered with a square cover glass (18 x 18 mm) in the presence of spacers with 
thickness of 0.15 mm. All vesicle samples were imaged using a 100X oil immersion 
objective. Laser wavelengths of 488 nm and 543 nm were used with high pass (LP 505) 
and band pass (BP 565−615) emission filters. 
 
4.2.4 Scanning Electron Microscopy 
 A cross-section of freeze-dried fractured vesicles was imaged with a Zeiss 
Ultra60 FE-SEM (Carl Zeiss). A vesicle sample was placed on a glass substrate and fixed 
with glutaraldehyde (1.0 %) for 1 hour. After washing twice with deionized water, the 
samples were freeze-dried and fractured. The vesicles were transferred to a carbon tape 
and sputter-coated with gold before imaging at 5 kV. Non-fractured vesicles were also 
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imaged as a control. The thickness of vesicle membrane was measured from a close-up 
image of a fractured vesicle.  
 
4.2.5 Dynamic Light Scattering 
 Hydrodynamic diameters of vesicles were measured with a Zetasizer Nano ZS 
(Malvern Instrument). A 4 mW He-Ne laser operating at a wavelength of 633 nm was 
equipped and operated at a detection angle of 173°. Vesicle solution samples (100 μL) 
were prepared in a cuvette, and measurements were performed at 25 °C. The raw 
correlation data were processed to size distribution by using Dispersion Technology 
Software.  
 
4.2.6 Circular Dichroism Spectroscopy 
 The CD spectra of protein complexes were recorded on a Jasco J-810 
spectropolarimeter (JASCO). Protein solution samples were prepared in PBS (pH 7.4), 
and measurements were performed in a 0.2-cm-length cuvette. The spectra were obtained 
in 1 nm increments within a wavelength range of 200 − 300 nm. Mean residue ellipticity 
was converted from accumulated spectra of five measurements for each sample. 
 
4.2.7 Turbidity Measurement 
 The turbidity of protein solutions was measured from the optical density of 
transmitted light at 400 nm, using a microplate reader (Synergy HT Multi-Mode, 
BioTeck). Absorption by the proteins is negligible at this wavelength. The protein 
solutions (100 μL) were prepared in a 96-well microplate at 4 °C and placed in the 
instrument at 25 °C. Then, the changes of turbidity were monitored by recording the 
optical density of protein solutions every minute for 100 min. 
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4.3 Results and Discussion 
4.3.1 Self-Assembly of Protein Vesicles 
 In the present study, protein vesicles were created by combinations of three 
different diblock recombinant proteins: ZR–ELP, mCherry–ZE, and EGFP–ZE (Figure 
4.1A). An ELP motif was conjugated with a coiled coil domain (ZR) as a fusion protein 
ZR–ELP.
51
 The arginine-rich leucine zipper motif (ZR) forms coiled coil complexes with 
its counterpart ZE.
49
 The glutamic acid-rich leucine zipper motif (ZE) was fused with two 
different fluorescent proteins, mCherry and EGFP. As illustrated in Figure 4.1B, the 
leucine zipper coiled coil (ZE/ZR) incorporates the globular domains into a “globule-rod–
coil” protein complex (mCherry–ZE/ZR–ELP or EGFP–ZE/ZR–ELP) via their high 




 Because of 




 ZR–ELP forms homodimers and 
was used as a temperature-responsive “rod–coil” protein amphiphile. The “globule-rod–
coil” and “rod–coil” protein complex amphiphiles are made first by mixing (Figure 
4.1B), where the globular and rod-shaped proteins serve as hydrophilic blocks. Circular 
dichroism spectroscopy confirms that each protein complex contains the α-helical coiled 
coil motifs (Figure 4.2). 
 By incubating the protein mixture at room temperature, ELP separates into a 
hydrophobic phase and the protein complexes self-assemble into vesicles in aqueous 
solution (Figure 4.1B). The protein mixture solution, prepared at 4 °C, was placed at 
room temperature for an hour and became turbid as a result of vesicle formation (Figure 
4.3). Figures 4.4A and 4.4B show protein vesicles self-assembled from ZR-ELP mixed 












Figure 4.1 Recombinant protein amphiphiles and their self-assembly into vesicles. (A) 
Recombinant diblock copolypeptides: ZR–ELP, mCherry–ZE, and EGFP–ZE (PDB ID: 
2H5Q for mCherry and 1EMK for EGFP). (B) The rod–coil (ZR-ELP homodimer) and 
‘globule-rod-coil’ (mCherry–ZE/ZR–ELP and EGFP–ZE/ZR–ELP) protein complexes 
prepared in solution at 4 °C self-assemble into hollow vesicles employing mCherry, 
EGFP, or both globular domains. Depending on conditions, EGFP–ZE can form a 





Figure 4.2 CD spectra of protein complexes ZR−ELP (black), mCherry−ZE/ZR−ELP 
(red), and EGFP−ZE/ZR−ELP (green). Mean residue ellipticity was measured from 






Figure 4.3 Photographs of a protein solution during inverse phase separation. A protein 
solution (300 μL) containing mCherry−ZE (1.5 μM) and ZR−ELP (30 μM) was prepared 
in a cuvette at 4 °C, and the photographs were taken at 0, 5, 15, 30, 60 min after placing 






Figure 4.4 Self-assembled protein vesicles. Confocal micrographs of vesicles prepared 
from solutions containing different concentrations of the recombinant protein 
components: (A) 1.5 μM of mCherry–ZE and 30 μM of ZR–ELP; (B) 0.6 μM of EGFP–ZE 
and 30 μM of ZR–ELP; (C) 0.3 μM of mCherry–ZE, 0.3 μM of EGFP–ZE, and 30 μM of 
ZR–ELP; (D) 1.5 μM of mCherry–ZE, 0.6 μM of EGFP–ZE, and 30 μM of ZR–ELP. Salt 
concentrations of the solutions were (A) 0.30 M, (B, C) 0.91 M, and (D) 0.45 M. 
Fluorescence from the vesicles was visualized using different colors, red (mCherry–ZE) 
and green (EGFP–ZE), which colocalize to yellow in (C). The insets are close-up images 
and the curves in (C) and (D) are fluorescence intensity profiles corresponding to the 




measurements (Figure 4.10A), the average diameters were 1.26 μm and 1.82 μm for 
vesicles incorporating mCherry and EGFP domains, respectively, with a narrow size 
distribution (polydispersity index < 0.03). The red and green fluorescence indicates 
homogenous incorporation of mCherry–ZE and EGFP–ZE in each vesicle membrane. 
Since the inverse phase transition of ELP does not involve use of any organic solvents 
and thus provides a biocompatible environment, no loss of fluorescence by denaturation 
of mCherry or EGFP was seen. Upon dilution of the vesicle solution, no significant 
change in fluorescence intensity was observed (Figure 4.5), indicating that mCherry–ZE 
is not exchanged between vesicles and solution due to the extremely low dissociation 
constant of ZE and ZR coiled coils. To confirm that the vesicles are hollow, we imaged 
cross-sections of fractured, freeze-dried vesicles. Scanning electron microscopy (SEM) 
images clearly show the empty inner space of a vesicle (Figure 4.6). Thickness of the 
vesicle membrane, measured from SEM images, was about 20 nm. 
 We found salt concentration to be a critical factor for vesicle formation. We tested 
the inverse phase transition of protein mixture solutions at different salt concentrations 
(0.15 M – 1.21 M) with a fixed concentration of ZR–ELP (30 µM). Vesicle formation was 
only observed above critical values of salt concentration, which are estimated to be 
approximately 0.30 and 0.91 M for vesicles incorporating mCherry–ZE and EGFP–ZE, 
respectively. Below these concentrations, we only observed formation of coacervate 










Figure 4.5 Fluorescence intensity of vesicles after dilution. Vesicles of mCherry−ZE (1.5 
μM) and ZR−ELP (30 μM) were prepared on a glass substrate and diluted 10 times with 
PBS (0.45 M). After dilution, fluorescence from mCherry−ZE in a vesicle was monitored 
by imaging it at 0 min, 5 min, 15 min, and 30 min (A). The change in intensity was 





Figure 4.6 SEM images of protein vesicles. A vesicle sample of mCherry−ZE (1.5 μM) 
and ZR−ELP (30 μM) was fixed with glutaraldehyde for 1 h, and freeze-dried. Surface 
and cross-section were imaged from a non-fractured vesicle (A) and a fractured vesicle 
(B), respectively. A close-up image from a part of the vesicle in (B) was used to measure 




Figure 4.7 Confocal micrographs of protein coacervate. Formation of coacervate was 
observed from protein mixtures containing different concentrations of the recombinant 
protein components: (A) 1.5 μM of mCherry−ZE and 30 μM of ZR−ELP; (B) 0.6 μM of 
EGFP−ZE and 30 μM of ZR−ELP. The protein mixtures were prepared 4 °C with salt 
concentration of 0.15 M, and incubated at room temperature for an hour. Fluorescence 
from either mCherry−ZE (A) or EGFP−ZE (B) is visualized by red and green, respectively.  
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4.3.2 Molecular Packing 
 As probed by turbidity profiles, molecular packing of vesicles is distinct from that 
of coacervate particles (Figure 4.8). After an initial rapid increase, saturation of turbidity 
was observed at the salt concentrations for vesicle formation. It indicates that the surface 
of vesicles is hydrophilic and stable, which can be achieved via packing of the rod and 
globule-rod protein blocks. However, there was a slow decrease in turbidity when 
formation of coacervate particles was favored, either at lower salt concentrations or in the 
absence mCherry–ZE or EGFP–ZE. This decrease is caused by coalescence of protein 
coacervate particles,
108
 which indicates that they have hydrophobic surfaces where ELP 





Figure 4.8 Turbidity profiles of protein solutions during inverse phase transition. The 
optical density at 400 nm was monitored at 25 °C from the solutions prepared at 4 °C. 
(A) Molar ratio of mCherry–ZE to ZR–ELP (χ) was 0.05 and 0 at different salt 
concentrations (0.15 and 0.30 M). (B) Protein solutions contain 1.5 μM of mCherry–ZE 
(red), 0.6 μM of EGFP–ZE (green), and both (blue) at salt concentration of 0.45 M. All 





Figure 4.9 Molecular packing of protein complex amphiphiles. (A) Truncated cone 
models for ZR–ELP homodimer and mCherry–ZE/ZR–ELP to explain the packing 
parameter P. (B) A proposed model of single-layer vesicular membrane.  
 
 
 The effect of salt concentration can be further rationalized using the packing 
parameter, P = V/(a0lc).
110
 V is the volume of the hydrophobic (ELP) block, a0 is the 
average head area of the hydrophilic block, and lc is the critical length (Figure 4.9A). The 
hydrophilic part is composed of the globular domain (mCherry or EGFP) and the rod-
shaped coiled coils (mixtures of ZR/ZR homodimers or ZE/ZR heterodimers). When 
mCherry–ZE (or EGFP–ZE) is mixed with ZR–ELP, the average head area per single 
strand of ELP (a0) is expressed as a0 = (1 – χ)a1/2 + χa2, where χ is the molar ratio of 
mCherry–ZE (or EGFP–ZE) to ZR–ELP, and a1 and a2 are the head areas of ZR/ZR and 
mCherry(EGFP)–ZE/ZR, respectively (Figure 4.9A). Because of fixed secondary structure 
and surface properties of the globule and rod blocks, a0 should not strongly depend on 
salt concentration. In contrast, V is significantly influenced by ionic strength. According 
to conformational mechanics of ELPs,
111
 ELP molecules are more collapsed with 
increasing salt concentration. Therefore, increased ionic strength reduces V and decreases 
the packing parameter P. In this sense, the protein amphiphiles have an inverted cone 
shape that forms coacervate particles when P > 1, below the critical values of salt 
concentration. Above the critical values, V is reduced, and vesicle formation is favored at 
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1/2 < P < 1. Therefore, conformational dependency of ELP on ionic strength seems 
strongly related to morphologies of the aggregates made from the protein amphiphiles. 
 Moreover, our argument based on the packing parameter clearly explains why the 
critical salt concentration is dependent on the type of globular domains. As demonstrated, 
P is also dependent on the average head area a0 that changes as a function of the molar 
ratio χ and a2. Importantly, the head area a2 is decided by the nature of globular domains, 
as they are covalently linked to ZE/ZR coiled coils (Figure 4.9A). For example, mCherry 
is a monomeric and highly soluble globular protein,
112
 and a2 becomes larger than the 
head area resulted only from a coiled coil (~ a1) because of steric hindrance provided by 
the conjugated mCherry domain. In contrast, EGFP tends to dimerize at millimolar 
concentration
113
 or even can aggregate as indicated by the bright spots observed in Figure 
4.4B. The attraction between EGFP domains reduces a2 corresponding to EGFP–ZE/ZR 
block. Thus, the salt concentration required for 1/2 < P < 1 should be higher for EGFP 
than mCherry. 
 Our observation on the correlation between χ and the average hydrodynamic 
diameter of vesicles (dH) strongly evidences the influence of globular domains on the 
packing parameter P. With increasing χ at a given salt concentration, dH of mCherry–ZE 
vesicles decreased while we observed an increase in dH of EGFP–ZE vesicles (Figure 
4.10). The increased curvature of mCherry–ZE vesicles at higher χ indicates a2 > a1, and 
a2 < a1 for EGFP-ZE vesicles since their curvature decreases with increasing χ. Thus, 
mCherry provides a larger head area (a2) than EGFP since a1 is independent of the 
globular domains. These opposite trends, with equally increased fractions of ZE/ZR coiled 
coils in both systems, indicate that influence from the globular domains seems to be 
dominant over interactions between ZR/ZR and ZE/ZR coiled coil domains. Nonetheless, 






Figure 4.10 Hydrodynamic diameter (dH) of vesicles with different molar ratios (χ). (A) 
Size distribution obtained from DLS measurement. Molar ratio of mCherry–ZE to ZR–
ELP (top), 0.01, 0.02, 0.03, 0.05, 0.1; EGFP–ZE to ZR–ELP (bottom), 0.01, 0.02, 0.03, 
0.05. Concentration of ZR–ELP was fixed at 30 μM for all samples at different salt 
concentrations: 0.30 M (mCherry–ZE vesicles) and 0.91 M (EGFP–ZE vesicles). (B) The 





 When vesicle formation conditions are favorable for both globular domains, we 
found that both mCherry–ZE and EGFP–ZE were incorporated into membrane of hollow 
vesicles (Figure 4.4C). Surprisingly, at a condition where only formation of mCherry–ZE 
vesicles is favored, the two globular domains separated into different micro-phases within 
a vesicle (Figure 4.4D). The confocal micrograph indicates that mCherry–ZE and ZR–ELP 
self-assembled into vesicles whose interior is filled with EGFP–ZE and ZR–ELP. 
Different from the hollow vesicles incorporating both globular domains in the membrane, 
this condition resulted in vesicles with “core-shell” morphology. According to the 
observed morphological dependence on salt concentration, the vesicular layer composed 
 57 
of mCherry–ZE and ZR–ELP encapsulates the coacervate phase of EGFP–ZE and ZR–
ELP, which was simultaneously formed during the inverse phase transition. Again, as 
probed by turbidity profiles, the saturation in turbidity after phase transition indicates that 
the “shell” is a stable vesicular membrane of tightly packed protein amphiphiles (Figure 
4.8B). At the same salt concentration, however, the turbidity profile for the mixture of 
only EGFP–ZE and ZR–ELP showed a gradual decrease, which indicates formation of 
typical coacervate particles. This demonstrates that vesicles incorporating multiple types 
of globular domains in either the membrane or interior compartment can self-assemble by 
adjusting salt concentration. 
 Preferential encapsulation of the coacervate phase could be explained by a 
hypothetical model of vesicles composed of a self-assembled “single-layer” membrane. It 
is distinguished from “bilayer” membranes of typical block copolymer vesicles. In a 
bilayer, hydrophilic chains are both inside and outside of vesicles. In our proposed model, 
the hydrophobic ELP blocks are facing the interior (Figure 4.9B) and the inner surface 
could stabilize the encapsulated protein coacervate phase. An example of synthetic rod-
coil block copolymers demonstrates that they form hollow aggregates where a 
hydrophobic inner shell encapsulates hydrophobic cargo.
114
 Despite the globular domains 
included in our system, this example shares the same characteristic of rod-shaped blocks 
directly interfaced with hydrophobic coil blocks. We hypothesize that the rigid, rod-
shaped conformations could maintain a low interfacial curvature between the coiled coils 
and ELP, and may prevent collapse of hollow structure even in the absence of 
encapsulated coacervate phase.
102
 Moreover, our observation of correlation between 
packing parameter and curvature of vesicles (Figure 4.10) is similar to a characteristic of 
single-layer superstructures assembled from mesoscopic metal-polymer amphiphiles.
115 
 In addition to protein coacervate, encapsulation of small molecules can be simply 
achieved by mixing with the protein amphiphiles, followed by inverse phase transition. 
As a model molecule, fluorescein was mixed with mCherry–ZE and ZR–ELP at 4 °C and 
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warmed to room temperature. As a result, the inner space of resulting vesicles was filled 
with fluorescein, as shown in the confocal micrograph (Figure 4.11A). The level of 





Figure 4.11 Encapsulation of cargo by protein vesicles. Confocal micrographs of vesicles 
encapsulating (A) fluorescein and (B) polystyrene nanoparticles. Vesicles of mCherry–ZE 
(1.5 μM) and ZR-ELP (30 μM) were self-assembled in the presence of fluorescein (50 
μg/mL) or fluorescent polystyrene nanoparticles with diameters of 500 nm (125 μg/mL). 
Salt concentration was 0.45 M. The green color indicates fluorescence from (A) 
fluorescein and (B) polystyrene nanoparticles while fluorescence from mCherry–ZE is 




 Importantly, when mCherry–ZE vesicles were assembled in the presence of 
carboxylated fluorescent polystyrene nanoparticles (diameter ~ 500 nm), we observed the 
nanoparticles located inside the resulting vesicles (Figure 4.11B). The confocal 
micrograph shows the green fluorescent particles surrounded by the red fluorescent 
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vesicular membrane. This result could be explained if the vesicle membrane provides a 
hydrophobic inner wall. Considering the low number density and length scale of the 
nanoparticles relative to vesicles, encapsulation should be driven by attractive 
interactions between the hydrophobic nanoparticles and inner wall of the membrane. 
Indeed, the protein vesicles can encapsulate cargo with multiple length scales: small 
molecules (~ 10
0
 nm), proteins (~ 10
1





 In conclusion, we describe the aqueous self-assembly of protein vesicles that 
incorporate globular domains as building blocks via temperature-responsive inverse 
phase transition. It provides a versatile method to fabricate protein vesicles in 
biocompatible environments. Thus, folded and biologically functional proteins, such as 
enzymes or receptor ligands, could be incorporated into vesicle membranes for practical 
applications. Importantly, the simple and efficient encapsulation of various types of cargo 




SELF-ASSEMBLY OF PROTEIN NANOSHEETS 
5.1 Introduction 
 Sequence-defined biopolymers such as peptides or proteins offer opportunities for 
programmed self-assembly. Supramolecular interactions dictated by the sequence of 







 Furthermore, two-dimensional (2D) structures can be assembled 
from peptides. Recently, self-assembly of 2D nanosheets has been demonstrated using 
short peptide amphiphiles
116
 or collagen-mimetic peptides.
117,118
 Self-assembly of those 
synthetic peptides is driven by amphiphilic properties or charge complementarity 
between triple helices, respectively. Also, peptoids, poly-N-substituted glycines, have 
been used to fabricate self-assembled nanosheets.
119,120
 Control over the sequence of 
periodic amphiphilic peptoids allowed electrostatic recognition and aromatic interactions 
to direct 2D self-assembly. 
 Recombinant proteins may offer more opportunities in design of self-assembling 
building blocks. In contrast to short peptides or peptoids, domains with specific 
secondary structures can be incorporated, which can diversify programmed 
supramolecular interactions. Formation of various 3D suprastructures including fibers, 
sheets, and vesicles, was demonstrated in self-assembly of oleosin-based recombinant 
proteins.
104
 However, suprastructures with well-defined 2D geometry have not been 




 Here, we describe self-assembly of 2D nanosheets from recombinant proteins. A 
recombinant protein building block containing two identical rod-shaped leucine zipper 
coiled coils was designed, and its assembly into 2D nanosheets was directed under 
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controlled processes. In addition, the self-assembled nanosheets can incorporate folded 
globular proteins through high-affinity binding of leucine zipper motifs, which is 
beneficial for further applications. 
 
5.2 Experimental Details 
5.2.1 Materials 
 Ruthenium tetroxide (RuO4) was purchased from Sigma-Aldrich. PBS (1X, pH 
7.4) containing NaCl (137 mM), KCl (2.7 mM), Na2HPO4 (10 mM), KH2PO4 (1.8 mM) 
was prepared in the lab. 
 
5.2.2 Self-Assembly of Protein Nanosheets 
 The first method is stirring-induced self-assembly. After 100 µL of mCherry−ZE 
or EGFP−ZE solution (10 µM) was added to 900 µL of ZR−C10−ZR solution (11.1 µM) 
prepared in PBS (pH 7.4), the protein mixture solution was stirred at 600 rpm for 24 hr at 
4°C. 
 The second method is based on drying of proteins on glass substrates. A solution 
of ZR−C10−ZR (1 mg/ml) was prepared in PBS (pH 7.4), and 10 µL droplets were placed 
on glass substrates. After drying overnight at ambient conditions, salt crystals formed on 
the glass substrates were carefully rinsed with PBS. Next, 10 µL of mCherry−ZE or 
EGFP−ZE (1 µM) was applied to the nanosheets on the glass, and incubated for 1 hr. 
After washing with PBS, the samples were characterized using fluorescence microscopy.  
 
5.2.3 Characterization of Protein Nanosheets 
Fluorescence Microscopy 
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 Fluorescence micrographs were obtained with a Axio Observer.Z1 (Carl Zeiss). 
Samples were placed on glass substrates, fluorescence from mCherry (excitation: 565/30 
nm, emission: 620/60 nm) and EGFP (excitation: 474/40 nm, emission: 525/50 nm) was 
visualized using 10X, 40X, and 100X (oil immersion) objectives.  
Scanning Electron Microscopy (SEM) 
 SEM images were collected on a Hitachi SU8230. After washing with deionized 
water, 100 μL of sample solution was freeze-dried and mounted on a stub using carbon 
tape. After sputter coating with gold, the samples were imaged at 12 kV. 
Transmission Electron Microscopy (TEM) 
 TEM images were collected on a JEOL electron microscope (JEOL 100CX) at an 
acceleration voltage of 100 kV. For TEM imaging, 5μL of protein nanosheets solutions 
were sampled by dropping on the TEM grids. Samples were stained by an exposure to 
0.5% RuO4 vapor for 20 min. 
Fourier Transform Infrared (FT-IR) 
 FT-IR spectra of protein nanosheets were obtained with a Nicolet iS50 FT-IR 
spectrometer (Thermo Scientific) in attenuated total reflection (ATR) mode. The spectra 
were recorded for wavenumbers ranging from 400 to 4,000 cm
−1
. Samples were prepared 
on a glass substrate, and transferred onto the ATR crystal. 
 
5.2.4 Circular Dichroism Spectroscopy 
 A solution of ZR−C10−ZR (10 µM) was prepared in PBS (pH 7.4) and placed in a 
0.2-cm-length cuvette. Using a Jasco J-810 spectropolarimeter (JASCO), a CD spectrum 
was obtained in 1 nm increments within a wavelength range of 200 − 300 nm. Five 
measurements were accumulated, and converted to mean residue ellipticity. 
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5.3 Results and Discussion 
5.3.1 Free-Floating Colloidal Protein Nanosheets 
 In Chapter 4, we investigated the ability of the packing parameter to dictate 
morphology of self-assembled protein structures. Based on our findings, we hypothesized 
that protein building blocks with cylindrical geometry may self-assemble into sheet-like 
morphologies. The tri-block copolypeptide ZR−C10−ZR contains two leucine zipper 
motifs that are connected by a flexible linker. Since the weaker affinity between ZR 
motifs (Kd ≈ 10
−7
 M) induces formation of a parallel ZR/ZR coiled coils,
49
 homodimers of 
ZR−C10−ZR are favored to form in aqueous solution (Figure 5.1A and Figure 2.3). In the 
dimeric protein complexes, two pairs of the rod-shaped coiled coils (ZR/ZR), which are 
located at both N and C termini, are hypothesized to result in cylindrical geometry, 
together with the flexible random coil mid-part, C10. In the CD spectrum of ZR−C10−ZR 
(Figure 5.1B), the peaks at 222 nm indicates presence of α-helical coiled coils. Also, the 
peak at 206 nm is a characteristic of random coils.
122
  
 Incubation of protein solutions without agitation did not result in formation of any 
particles, because ZR/ZR coiled coils can only dimerize
49
 and C10 does not possess 
spontaneous self-assembling properties.
58
 However, when protein mixture solutions were 
stirred for 24 hr at 4°C, the solution became turbid and formation of fluorescent particles 
was observed (Figure 5.2A and 5.2B). Fluorescence from the particles indicates that 
either mCherry−ZE or EGFP−ZE was incorporated. Although morphology of the particles 
was not clear in the fluorescence micrographs, we observed particles that look like rolled 
sheets in SEM images (Figure 5.2C). Furthermore, a TEM image shows formation of 
thin, sheet-like particles (Figure 5.2D). The folded area of the sheets (inset image) 
indicates a thickness of 13.7 nm. Indeed, recombinant protein building blocks self-









Figure 5.1 Recombinant protein building blocks and proposed lateral self-assembly into 
nanosheets. (A) Cylindrical protein complexes (homodimers of ZR−C10−ZR) self-
assemble into nanosheets and mCherry−ZE (or EGFP−ZE) is incorporated. (B) The CD 









Figure 5.2 Free-floating colloidal protein nanosheets. (A, B) Fluorescence micrographs 
of protein nanosheets from stirred mixtures: (A) ZR−C10−ZR (10 µM) and mCherry−ZE (1 
µM); (B) ZR−C10−ZR (10 µM) and EGFP−ZE (1 µM). (C) SEM image of freeze-dried 





5.3.2 Large-Area Protein Nanosheets 
 Although the stirring-induced self-assembly resulted in formation of particulates 
with sheet-like morphologies, we further developed processes that can direct self-
assembly of large-area nanosheets with a well-defined geometry. Zuckermann et al. 
demonstrated that compression at the air-water interface catalyzes self-assembly of 
peptoids.
120
 Similarly, we hypothesized that flat solid surfaces may serve as a template 
that can assist in alignment of the cylindrical building blocks. In this process, ZR−C10−ZR 
was dried on glass substrates, followed by incubation with solutions containing 
mCherry−ZE or EGFP−ZE. As a result, large-area fluorescent sheets were formed on the 
substrates (Figure 5.3). Widths of the sheets were around 180 µm for the volume of 
solution used, and the fluorescence indicates incorporation of mCherry−ZE or EGFP−ZE. 
Also, the sheets were able to be resuspended in solution, although they were significantly 
folded (Figure 5.3C). We observed formation of wrinkles, which is also a characteristic 
of sheet-like morphologies (Figure 5.3A and 5.3B).
119,120
 
 Lateral assembly of cylindrical protein building blocks is our proposed model for 
molecular packing in nanosheets (Figure 5.1A). Although direct characterization such as 
high-resolution TEM is required, our observations in FT-IR spectra can be explained by 
the hypothetical model. The amide I bands for soluble (1645 cm
−1
) and assembled 
ZR−C10−ZR (1646 cm
−1
) were almost identical, indicating ZR−C10−ZR did not undergo 
conformational transition during self-assembly, for example, from α-helix to β-sheet 
(Figure 5.4). The result confirms that nanosheets contain α-helical coiled coils. Also, we 
observed that the peak at 1391 cm
−1
 was significantly reduced when nanosheets were 
assembled. This peak is assigned for symmetric bending vibration of CH3 groups,
123
 
which are dominantly present in alanine-rich C10. With normalization of the amide I 
bands, such a decrease in intensity of the peak can be indicative of changes in interactions 
between and the CH3 groups and surroundings. Thus, we hypothesize that the 
hydrophobic side chains of C10 might contribute to attraction between building blocks. 
 67 







Figure 5.3 Large-area protein nanosheets. (A-C) Fluorescence micrographs of protein 
nanosheets from drying of ZR−C10−ZR followed by incubation with mCherry−ZE (1 µM) 
(A, B). The nanosheets are resuspended in PBS (C). (D) Nanosheets of ZR−C10−ZR 





Figure 5.4 FT-IR spectra of soluble (black) and assembled ZR−C10−ZR (blue). 
 
 
 The underlying mechanism for drying-induced self-assembly needs to be 
elucidated. Although we hypothesized that a substrate surface may serve as template, it is 
also possible that the air-water interface of droplets might direct self-assembly. Real-time 
observation of the self-assembly process may be a route to gain more mechanistic 
information, for example, by using dye-conjugated ZR−C10−ZR protein building blocks 
and time-lapse fluorescence microscopy. For example, nucleation and growth behaviors 
might be visualized.
124
 Acquisition of such information will also allow improved control 




 We described self-assembly of nanosheets from recombinant proteins, which was 
induced by stirring or drying. The drying-induced self-assembly resulted in formation of 
large protein sheets (>180 µm in width), and folded protein domains such as mCherry or 
EGFP were incorporated into nanosheets. We propose a model that cylindrical building 
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blocks laterally self-assemble into nanosheets. Our strategy can allow scaled-up 
production of large-area protein nanosheets. The unique morphology with incorporated 
folded proteins will offer opportunities for applications such as protein delivery, wound 




HIERARCHICALLY STRUCTURED POROUS PROTEIN-
INORGANIC HYBRID SUPRAPARTICLES 
6.1 Introduction 
 Structural features of biominerals, the natural composite materials, include 
complexity in morphology and hierarchy at multiple length scales. In nature, diverse 







and hard components from many organisms
127
 are composed of highly organized 
inorganic nanocrystals and biomolecules, and the complex hybrid structures are produced 
through biomineralization.
126
 During the natural process, biomolecules interacting with 
mineral phases regulate formation of biominerals, which is followed by arrangement of 
hybrid nanostructures into higher-order structures at the microscale.
7,126
 There have been 
attempts to mimic nature’s strategy to fabricate composite materials by biomineralization. 







 have been used as biotemplates. However, arrangement of 
biominerals beyond their growth on the templates was not achieved. Rational design of 
biomimetic strategies to create complex structures has been challenging because the 
fundamental growth mechanism for biominerals remains largely hypothetical.
130
 Recent 
studies have demonstrated strategies to fabricate more complex hierarchical structures in 
which biominerals nanocrystals were aligned.
133,134
 Nonetheless, arrangement of 
inorganic nanocrystals and organic phases into hierarchically ordered structures in three-
dimensions is a long-sought goal in the design of artificial biominerals. Also, simplicity 
and reproducibility of fabrication methods are critical for practical application of 
nanocomposite materials. 
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 Here, we report a simple strategy to fabricate hierarchically structured protein-
inorganic hybrid supraparticles. Recently, synthesis of artificial protein-inorganic hybrids 
with flower-like shapes has been reported.
135,136
 The hybrid particles are composed of 
petal-like plates, which are interconnected into the flower shapes. Motivated by this 
shape, we used flower-shaped particles as building blocks that can self-assemble into 
higher-order architectures. In our system, we created flower-shaped protein-calcium 
phosphate hybrid nanoparticles which assemble into chain-like clusters. The pores and 
petals of nanoparticles provide “interlocking” interactions by their self-complementary 
geometry. By controlling assembly behavior, the building blocks were arranged into 
supraparticles with pores at both the nano- and microscales. 
  In addition to hierarchical structure, the hybrid supraparticles provide high-
affinity binding sites for robust protein immobilization. Proteins can be stabilized through 
immobilization on solid supports,
137
 which are beneficial for applications such as 
biocatalysis and biosensors. One strategy is to create fusion proteins that have a binding 
affinity to supports. The supraparticles incorporate leucine zipper motifs, to which fusion 
proteins that carry the pairing zipper motifs can specifically bind with femtomolar 
affinity. Our approach enables immobilization of various types of proteins as it is based 
on specific binding affinity between leucine zipper motifs, not protein-specific 





6.2 Experimental Details 
6.2.1 Materials 
 Calcium chloride dihydrate (CaCl2·2H2O) was purchased from Fisher Chemical. 
Concentrated PBS (10X, pH 7.4) containing NaCl (1.37 M), KCl (27 mM), Na2HPO4 
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(100 mM), KH2PO4 (18 mM) was prepared in the lab and used to dissolve proteins and 
adjust salt concentration in aqueous solution. 
 
6.2.2 Synthesis and Characterization of Hybrid Nanoparticles 
 Lyophilized recombinant fusion protein ZR−C10−ZR was dissolved in deionized 
water at a concentration of 1 mg/ mL, and diluted into 0.1 mg/mL in 1X PBS (pH 7.4). 
An aqueous solution of CaCl2 (160 mM) was prepared, and 10 µL was added to 1 mL of 
ZR−C10−ZR solution (0.1 mg/ mL). The mixture solution was left undisturbed for 1 day at 
room temperature. The hybrid nanoparticles formed in solution were characterized with 
optical microscopy (Axio Observer.Z1, Carl Zeiss). On a glass substrate, 5 µL of sample 
was placed and imaged using a 100X oil immersion objective. Also, the nanoparticles 
were washed by centrifugation and resuspended in deionized water. Then, 5 µL of the 
washed nanoparticles were dried on aluminum substrates overnight at room temperature 
for SEM characterization using Zeiss Ultra60 FE-SEM (Carl Zeiss). The samples were 
sputter-coated with gold and imaged at 5 kV. As a control, 10 µL of CaCl2 was added to 
1 mL PBS without any proteins, and the resulting precipitates were collected, washed, 
and imaged with SEM following the same procedures. 
 
6.2.3 Colloidal Assembly and Characterization of Supraparticles  
 After addition of 10 µL of CaCl2 (160 mM) into 1 mL of ZR−C10−ZR solution (0.1 
mg/ml), a microtube (volume: 2 mL) containing the mixture solution was immediately 
placed in a rotator (Thermo Scientific). Rotation (8 rpm) was continued for 2 days at 
room temperature. Next, the resulting solution was collected and mixed with 14 mL of 
deionized water. After sitting undisturbed overnight at room temperature, 14 mL of 
supernatant was carefully removed. Again, 14 mL of deionized water was added, and 
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supernatant was removed after 1 hr incubation. The resulting supraparticles in solution 
were characterized using optical microscopy (10X or 40X objectives). Dried samples 
were characterized using SEM, following the same procedures of sample preparation 
mentioned above. For characterization of cross-sections, dried supraparticles on the 
substrate were fractured by rubbing with tweezers. To monitor the assembly process, 
samples were taken at 30 min, 2 hr, 8 hr, and 24 hr during rotation, and imaged using 
optical microscopy (10X objective). 
 
6.2.4 Protein Immobilization 
 Solutions containing 5 µM of mCherry−ZE or EGFP−ZE were prepared in 1X 
PBS (pH 7.4). Then, 20 µL of the solution of mCherry−ZE was added into 80 µL of the 
supraparticle solutions, which was incubated for 1 hr at room temperature. For 
immobilization of multiple proteins, 20 µL of mCherry−ZE solution (5 µM) was added 
into 60 µL of the supraparticle solutions and incubated for 10 min, followed by addition 
of 20 µL of EGFP−ZE solution (5 µM). The mixture solution containing supraparticles, 
mCherry−ZE, and EGFP−ZE were incubated for 1 hr at room temperature. For 
characterization of protein immobilization, 5 µL of samples were taken and placed on a 
glass substrate. Using a confocal microscope (Zeiss LSM 510 Vis, Carl Zeiss), 
fluorescence from the fusion proteins immobilized on the supraparticles was visualized 
and intensity profiles were quantified from the fluorescence images. All supraparticle 
samples were imaged using a 40X objective. The images with EGFP fluorescence was 
acquired using a 488 nm Argon laser line with high pass (LP 505) emission filter, and 
mCherry fluorescence were imaged using a 543 nm He-Ne laser line with band pass (BP 




6.3 Results and Discussion 
6.3.1 Flower-Shaped Hybrid Nanoparticles 
 We first prepared a recombinant fusion protein that can form a hybrid with 
calcium phosphate. In calcium-binding protein domains, oxygen atoms of the carboxyl 
groups in aspartic acids or glutamic acids, and backbone chains have coordination with 
calcium ions.
138,139
 We hypothesized that the artificial random coil C10 can coordinate 
with calcium ions. A single chain of C10 contains ten glutamic acid residues. Also, it is 
flexible in conformation,
59
 which may allow oxygen atoms in the backbone chain to have 
coordination with calcium ions. Similarly, in the synthesis of protein-copper phosphate 
hybrid nanoflowers, it was proposed that nitrogen atoms accessible to the ions in solvent 
have coordinated interactions with copper ions.
135
 From a practical aspect, C10 was 
combined with a high-affinity protein motif (ZR) into a tri-block copolypeptide 
ZR−C10−ZR (Figure 6.1). That way, the hybrid of calcium phosphate and ZR−C10−ZR can 
provide affinity-binding sites to recombinant proteins carrying ZE via robust binding with 
femtomolar affinity.
49
 This property is considered to be beneficial for protein 
immobilization. Since ZR is α-helical and contains only few glutamic acid residues, it is 
hypothesized that C10 would dominantly interact with calcium ions. As described in 
Chapter 2, ZR−C10−ZR was produced from an E. coli expression system. 
 Next, the protein-calcium phosphate hybrid particles were synthesized by co-
precipitation of calcium and phosphate ions in the presence of ZR−C10−ZR (Figure 6.1). 
Upon addition of calcium chloride into solution of ZR−C10−ZR prepared in PBS, 
immediate precipitation of calcium phosphate was observed. As shown in Figure 6.1, 
formation of flower-shaped particles was confirmed from SEM images. The flower-like 
shape is composed of petal-like plates with an average thickness of 15 nm, and the 
diameter of a whole particle ranged between 445 and 584 nm. In contrast, calcium 
phosphate precipitated in the absence of ZR−C10−ZR had only plate-like morphology 
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(Figure 6.1). It evidences our hypothesis that ZR−C10−ZR has coordinated interaction with 
calcium ions, which might be involved in nucleation of calcium phosphate and 







Figure 6.1 Synthesis of flower-shaped hybrid nanoparticles. (A) Scheme of co-
precipitation of calcium phosphate and ZR−C10−ZR. (B) SEM image of a hybrid 








Figure 6.2 Clusters of the flower-shaped nanoparticles. (A) A bright field image of self-
assembled cluster chains in aqueous solution. (B) SEM image of a cluster chain. (C) DLS 
measurement of the cluster chains in aqueous solution: the size distribution curves were 
obtained at 2 min, 5 min, 10 min, and 15 min after formation of the hybrid nanoparticles 
was initiated. (D) Schematic illustration of colloidal assembly of nanoparticles clusters. 
 
 
 Surprisingly, the flower-shaped hybrid nanoparticles started to assemble into 
chain-like clusters immediately after their synthesis. In aqueous solution, formation of 
colloidal clusters was observed, and they were also imaged by SEM after drying in 
ambient conditions (Figure 6.2A,B). In the chain-like clusters, the edges of petals were 
placed in the space between petals of other particles, resulting in overlapping of the 
boundaries of particles. DLS measurement indicates that hydrodynamic diameter of the 
particles was 1084 nm at 2 min after the co-precipitation, and it increased up to 2964 nm 
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at 15 min as a result of the subsequent colloidal assembly (Figure 6.2C). The size of the 
clusters increased over the limit of DLS measurement and settled at the bottom of the 
cuvette after 30 min. 
 As illustrated in Figure 6.2D, the anisotropic assembly of the hybrid nanoparticles 
can be explained by considering attractive forces, interlocking interactions, and steric 
hindrance of the side of chains. The petals of calcium phosphate are nanoscale, and such 
nanocrystals of calcium phosphate are prone to agglomerate due to van der Waals 
forces.
140
 In a flower-shaped particle, several petals form a fixed configuration where the 
edge of petals and the pores between petals can have complementary geometry for a 
“interlocking” interaction.
141
 When petals are located inside the pores, attraction due to 
van der Waals forces can be increased. Thus, the free energy of the system would reach a 
local minimum as a result of assembly. The interlocking interaction at this “self-
complementary” geometry is distinguished from the “lock-and-key” interaction,
142
 which 
is driven by excluded volume effect.
142
 While mediated by depletion interactions, the free 
energy of the system is reduced by an increase of the entropy of depletant in the 
exclusion volume. In our system, assembly is assumed to be driven by van der Waals 
forces, and is irreversible. Additionally, assembly of a nanoparticle to the side of cluster 
chains is sterically hindered. On the side, the petals that are not involved in the 
interlocking interaction can prevent access of additional particles. Thus, addition of a 
particle would be favored at the end of clusters. Similarly, anisotropic assembly was also 




6.3.2 Supraparticles Assembled from the Hybrid Nanoparticles  
 Although the chain-like clusters of the hybrid nanoparticles is an interesting 
morphology, they are varied in length and susceptible to shear-induced deformation. 
Instead, we were motivated to exploit the clustering behavior to build hierarchically 
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structured and porous hybrid supraparticles. Still, there are challenges for controlled 
assembly of the nanoparticles. First, the steric hindrance between the sides of cluster 
chains can prevent their assembly into higher-order structures. Second, as the hybrid 
nanoparticles grow into micrometer-sized clusters, they tend to settle to the bottom of a 
container, significantly reducing collision frequency between long and short chains. 
 We hypothesized that rotation of nanoparticles solutions can solve these problems 
and may control the colloidal assembly. Continuous expansion and contraction of the air-
water interface by rotation can induce compression of objects adsorbed at the interface,
120
 
which might allow alignment of the cluster chains of nanoparticles. Upon precipitation, 
the solution was placed in a rotator and the solution was continuously rotated for 2 days 
at room temperature. As a result, we observed formation of spherical microparticles with 
an average diameter of 29.7 ± 10.5 µm (Figure 6.3B). Close-up optical microscopy 
images (Figure 6.3C) also show the internal structures of the resulting supraparticles. We 
further characterized the supraparticles using SEM. Although they shrink slightly during 
drying process, the dried supraparticles show hierarchical pore structures on the surfaces 
(Figure 6.3D,E). 
 Surface morphology of the supraparticles evidences that they are assembled from 
the flower-shaped hybrid nanoparticles. Groups of petals form porous structures at the 
nanoscale while the nanoparticles cluster to result in pores at the microscale (Figure 
6.4A,B). Although the petals on the surface look a little compressed, the overall surface 
morphology of the supraparticles indicates that they are formed through an assembly of 
the clusters. Indeed, the flower-like structural characteristics of individual nanoparticles 
were translated into the hierarchical morphology of the self-assembled supraparticles. 
 Interestingly, we observed a spatial difference in density of nanostructures 
throughout the supraparticles. As shown in the SEM image of the cross-section (Figure 






Figure 6.3 Colloidal assembly of flower-shaped hybrid nanoparticles into hierarchically 
structured porous supraparticles. (A) Scheme of the rotation method that drives colloidal 
assembly. (B, C) Bright field images of supraparticles in aqueous solution. (D, E) SEM 








Figure 6.4 Morphology of self-assembled supraparticles. (A, B) SEM images showing 
surface morphology of a supraparticle. (C) Cross-section image of a fractured 




supraparticles whereas there was a dense packing in the rim. According to the 
morphologies, it is speculated that packing of cluster chains might have first occurred to 
form the core, followed by assembly of additional clusters to surface of the core. In this 
scenario, stacking of shorter cluster chains on the core seems to lead to higher structural 
density in the rim. 
 This scenario should be strongly related to the growth mechanism of the 
supraparticles. In order to investigate the mechanism, we monitored formation of 
supraparticles as a function of time during rotation of solutions (Figure 6.5). At the early 
stage (30 min), spherical agglomerates (arrowed, red) were formed while the majority of 
flower-shaped nanoparticles remained as giant networks of cluster chains. Interestingly, 
we could also observe rod-shaped particles (arrowed, blue) in this early stage. At 2 hr, 
formation of spherical agglomerates (arrowed, red) was also observed whereas the size of 
giant networks of cluster chains was much reduced. As assembly proceeded for 8 hr, 
more spherical supraparticles with higher contrast were observed, which indicates that 
structural density of the supraparticles was increased. After 24 hr, larger supraparticles 
with clear rims were observed while the size and number of cluster chains were reduced. 
According to the observations, our hypothesis for growth mechanism is that spherical 
agglomerates are first formed in the early stage and they serve as “seeds” on to which 
more clusters are assembled in the following stages. Both increased contrast and clear 
rims of supraparticles indicates formation of denser packing on the seeds. Thus, our 
hypothetical growth mechanism is consistent with the observed spatial difference in 
structural density inside supraparticles. 
 Formation of rod-shaped supraparticles in the early stage indicates that rotation 
method enabled lateral assembly of linear cluster chains. It is consistent with our design 
rational that compression at the air-water interface might allow alignment of the cluster 
chains. Since linear clustering of the flower-shaped nanoparticles up to several 
micrometers might not be dominant, we believe that only a fraction of rod-shaped 
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supraparticles forms while bent chains assemble into the spherical seed particles. In a 
control experiment, we left a nanoparticle solution stagnant for 24 hr while exposed to 
the air-water interface. In another control experiment, a microtube was filled up with a 
nanoparticle solution and no air was allowed in the tube, followed by rotation for 24 hr. 
We only observed networks of cluster chains, no spherical supraparticles, in the solutions 
from each control experiment (Figure 6.6). The result evidences that both rotation and the 
air-water interface are critical for formation of supraparticles. Thus, we can conclude that 




Figure 6.5 Growth of self-assembled supraparticles. (A-D) Bright field images of 
samples from rotating solution at 30 min (A), 2 h (B), 8 h (C), and 24 h (D). The arrows 





Figure 6.6 Control experiments of colloidal assembly. (A, B) Bright field images of 
nanoparticles clusters from a solution left stagnant for 24 hr (A) and from a solution 
rotated for 24 hr without exposure to the air-water interface. 
 
 
 The proposed growth mechanism is analogous to “Ostwald ripening” which has 
been applied to explain growth of crystals.
143
 The spherical seeds formed in the early 
stage might have lower free energy whereas networks of cluster chains might be 
relatively unstable. Thus, we hypothesize that growth of seeds into larger particles by 
addition of small clusters is thermodynamically favored. Rotation continuously generates 
shear that can deform the giant networks of clusters into smaller pieces. Moreover, 
formation of seeds and subsequent growth seem to be catalyzed by compression at the 
air-water interface.   
 
6.3.3 Immobilization of Fusion Proteins  
 An important feature of the protein-calcium phosphate hybrid supraparticles is to 
provide affinity binding sites for protein immobilization. Fusion proteins containing ZE 
motifs can bind to the ZR motifs of the incorporated ZR−C10−ZR through the femtomolar 
affinity between ZE and ZR.
49
 We used fluorescent proteins as model proteins to 
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characterize protein immobilization. After incubation of mCherry−ZE for 1 hr, we could 
measure red fluorescence of the supraparticles, which indicates immobilization of 
mCherry−ZE (Figure 6.7). Furthermore, the fluorescence micrographs show that the 
supraparticles are composed of submicron clusters. Also, the highest fluorescence 
intensity was observed at the rim while the intensity in the core was much lower. It is 
consistent with the spatial difference in structural density (Figure 6.4). Considering the 
hydrodynamic diameter of mCherry−ZE, the macroporous supraparticles would not result 




Figure 6.7 Immobilization of mCherry−ZE. Confocal micrographs of supraparticle 
incubated with mCherry−ZE: (A) A center confocal slice of a supraparticle. (B, C) Close-
up images of the core and rim regions are in (B) and (C), respectively. (D) The 
fluorescence intensity profile from the image in (A). (E) Three-dimensional (3D) Z-stack 
image of the supraparticle images in (A). Scale bars in (B) and (C): 1 µm. 
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 Furthermore, multiple proteins can be immobilized. When both mCherry−ZE and 
EGFP−ZE were incubated, both proteins were immobilized on the supraparticles. The red 
and green fluorescence of the supraparticle confirms their immobilization (Figure 6.8). 
Co-localization of multiple types of proteins in a porous support is attractive for 
applications that require a synergistic interplay between different proteins in proximity 
such as enzyme cascades.
144
 Overall, our approach offers a simple method to immobilize 
proteins to supraparticles in aqueous phase, without involving complicated processes or 
use of organic solvents. Also, such immobilization through specific affinity can allow 
stabilization of enzymes with the control of their orientation. 
 
 
Figure 6.8 Immobilization of multiple proteins, mCherry−ZE and EGFP−ZE. (A-C) A 
center confocal slice of a supraparticle: an overlay (A), red (B), and green fluorescence 
(C). (D) The fluorescence intensity profiles from the overlay image (A). Scale bars in (B) 
and (C): 10 µm. 
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6.4 Conclusion 
 We have demonstrated fabrication of hierarchically structured porous protein-
inorganic hybrid supraparticles. It is a simple method to build porous particles with 
complex morphologies, which is achieved by interfacial assembly of self-clustering 
flower-shaped nanoparticles. We also investigated the growth mechanism that resulted in 
a structural gradient inside particles. Moreover, the incorporated protein ZR−C10−ZR 
provided high-affinity binding sites for fusion proteins containing the assembling pair ZE 
motifs. We anticipate enhancement of stability or biological activity of immobilized 




PROTEASE-IMMOBILIZED SUPRAPARTICLES FOR 
INACTIVATION OF TUMOR NECROSIS FACTOR-ΑLPHA 
7.1 Introduction 
 Tumor necrosis factor-alpha (TNF-α), a pro-inflammatory cytokine, plays an 
important role in inflammation.
145
 Because of its role in inflammatory environments, 
TNF-α has been a therapeutic target for treatments for autoimmune diseases such as 
rheumatoid arthritis.
146,147
 Anti-TNF-α antagonists including soluble TNF receptors 
(TNFR) and anti-TNF-α antibodies have been developed and approved for human 
use.
148,149
 For instance, Etanercept is the recombinant human TNFR2 coupled with Fc 
portion of human antibody, and Infliximab and Adalimumab are humanized mouse and 
human monoclonal anti-TNF-α antibodies. These antagonists are based on affinity 
binding toward TNF-α, which may be reversible and the anti-TNF-α antagonists may 
serve as a TNF-α reservoir.
150
 Moreover, infection risks are present during systemic 
inhibition of both soluble and trans-membrane TNF-α.
151,152
 Systemic administration of 
TNF antagonists can also chronically dampen physiologic functions of TNF-α.
153
 Thus, a 
new type of TNF-α inhibitor and strategies for local delivery are required for reduced 
adverse effects in the treatment of diseases related to chronic inflammation. 
 Arginine-specific gingipains (Rgps) are pathogen-derived cysteine proteases, 
which can inactivate TNF-α by proteolytic degradation. They are secreted from P. 
gingivalis, and prevent inflammatory responses by degrading TNF-α during 
infection.
64,154
 Since TNF-α is degraded, use of an Rgp as a TNF-α inhibitor does not 
cause risks of reversible activation of TNF-α. However, wild type Rgps are immunogenic 
and cause hemagglutination.
155
 RgpA contains multiple adhesin domains including the 
hemagglutinin-adhesin domain. Moreover, cell-surface receptors, for example, the 
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fibronectin receptor (α5β1 integrin) and protease-activated receptors (PARs) are 
susceptible to degradation by wild type Rgps.
63,156
 Especially, the complex of RgpA and 
lysine-specific gingipain (Kgp) binds to a variety of extracellular proteins and is involved 
in degradation of surface proteins on epithelial, fibroblast and endothelial cells. The 
monomeric Rgp (RgpB) is lack of adhesin domains, but the N-terminal sequence 
including catalytic domain is homologous to RgpA.
63
 The catalytic domain is similar to 
caspases, and the S1 pocket at the active site accommodates arginine side chains.
157
 
 Our strategy is to exploit only the catalytic domain of RgpA and immobilize it to 
porous supraparticles. In this way, adhesin domains are removed and immobilization can 
allow proteolysis of only soluble targets. Also, the supraparticles may enable local 
delivery of the enzymes with enhanced stability. In this study, we engineered a 
recombinant Rgp fusion protein, and investigated its function for inactivation of TNF-α. 
The catalytic domain of RgpA was extracted and fused with a leucine zipper motif. The 
fusion protein was immobilized to porous supraparticles, which were described in 
Chapter 6, and both soluble and immobilized enzymes were studied. 
 
7.2 Experimental Details 
7.2.1 Materials 
 Human TNF-α recombinant protein was purchased from Thermo Scientific and R 
& D Systems. Fluorescein-5-isothiocyanate (FITC) and actinomycin D were purchased 
from Sigma-Aldrich. Murine fibroblast L929 cells, RPMI-1640 medium and fetal bovine 
serum (FBS) were purchased from ATCC. The 3-4,5-dimethylthiazol-2-yl-2,5-
diphenyltetrazolium bromide (MTT) cell viability assay kit was purchased from Biotium. 
Dimethyl sulfoxide (DMSO) was purchased from Fisher Scientific. PBS (1X, pH 7.4) 
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containing NaCl (137 mM), KCl (2.7 mM), Na2HPO4 (10 mM), KH2PO4 (1.8 mM) was 
prepared in the lab. 
 
7.2.2 Conjugation of FTIC to TNF-α 
 Lyophilized recombinant TNF-α was reconstituted in deionized water at 20 
μg/mL. FITC was dissolved in sodium carbonate buffer (0.1 M, pH 9.0) at 1 mg/mL. 
Then, 0.1 mL of FITC solution was mixed with 0.1 mL of TNF-α solution, followed by 
incubation at room temperature for 2 hr. To this mixture, 0.3 mL of PBS (pH 7.4) was 
added, and the final solution was dialyzed in PBS to remove unreacted FITC, using a 
dialysis membrane with 6-8000 molecular weight cut-off. The dialyzed solution was 
applied to SDS-PAGE, and conjugation was confirmed by fluorescence imaging of SDS-
PAGE gels using a fluorescence/phospho-imager (Typhoon, GE Healthcare Life 
Sciences). Concentration of FITC-TNF was calculated from dilution and volume changes 
during dialysis.  
 
7.2.3 Enzymatic Activity Assay 
 FITC-conjugated TNF-α was incubated with the fusion protein pRgpACAT−ZE, 
and recovery of quenched fluorescence of FITC was measured. In a 96-well plate, 60 µL 
of RPMI-1640 medium supplemented with 2% FBS was added and incubated for 30 min 
at room temperature. Next, 10 µL of FITC-conjugated TNF-α was added to the prepared 
medium in the 96-well plate. Upon addition of 10 µL of pRgpACAT−ZE solutions, 
fluorescence was immediately measured, using a microplate reader (Synergy HT Multi-
Mode, BioTeck). After 30 min of incubation at 37 °C, measurement of fluorescence was 
repeated. Difference of the fluorescence intensities measured at 0 min and 30 min was 
calculated to assess the activity of pRgpACAT−ZE. Concentration of TNF-α in all of the 
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measured samples was 29.4 nM while concentration of pRgpACAT−ZE was adjusted to 0, 
2.94, and 29.4 nM. 
 
7.2.4 Immobilization of pRgpACAT−ZE and TNF-α Digestion Reaction 
 The hybrid supraparticles was first prepared as described in Chapter 6. Then, 12 
µL pRgpACAT−ZE (0.21 µM or 2.1 µM) was added to 8 µL of supraparticle solutions. 
After 1 hr incubation at room temperature, the supernatant was removed and 
supraparticles were washed with PBS and diluted in 100 µL of RPMI-1640 medium 
supplemented with 2% FBS. Solutions containing soluble pRgpACAT−ZE were also 
prepared at concentrations of 25 and 250 nM, by diluting a stock solution (550 µg/mL). 
Concentration of the stock solution was determined using absorbance at 280 nm 




). Next, 20 µL of solutions containing either 
soluble or immobilized pRgpACAT−ZE were added to 80 µL of TNF-α (62.5 nM) 
solutions prepared in the medium. For controls (0 nM enzyme), same volumes of PBS 
and a solution of supraparticles with no immobilized enzymes were incubated. The 
concentration of TNF-α in the reaction mixtures was 50 nM, and the final concentrations 
of both soluble and immobilized pRgpACAT−ZE were varied at 0, 5, and 50 nM. The 
reaction mixtures were incubated for 1 hr at 37°C and samples were taken, diluted in the 
medium, and transferred to the following TNF-α inactivation potency assay. 
 
7.2.5 TNF-α Inactivation Potency Assay 
 Inactivation of TNF-α by both soluble and immobilized pRgpACAT−ZE was 
measured using L929 bioassay.
158,159
 Murine L929 cells were cultured in RPMI-1640 
medium supplemented with 10% FBS. After resuspending in medium supplemented with 
2% FBS, the cells were seeded at 5 X 10
5
 cells/well in a 96-well plate for 16 hrs. 
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Digested reaction mixtures (equivalent to 10 ng/mL of active TNF-α) and actinomycin D 
(1 µg/mL) were added to the cells (200 µL). After 24 hrs, 10 µL of MTT solutions were 
added to each well and incubated for 4 hrs at 37°C. From each well, 110 µL medium was 
carefully removed and 200 µL of DMSO was directly added. To dissolve formazan salt, 
the medium in each well was well-mixed using pipettes. Absorbance at 570 nm was 
measured using a microplate reader, and absorbance at 630 nm was also measured for 
background. To measure cytotoxicity of soluble pRgpACAT−ZE, the enzymes (0, 2.5, 12.5 
nM) and TNF-α (0 or 10 ng/mL) were dosed to L929 cells (5 X 10
5
 cells/well). After 
incubation for 24 hrs, cell viability was measured using MTT assay. 
 
7.3 Results and Discussion 
7.3.1 Proteolysis of TNF-α 
 As described in Chapter 2, the catalytic domain of RgpA (RgpACAT), propeptide 
domain, and leucine zipper ZE were combined into a fusion protein pRgpACAT−ZE. To 
assess proteolytic activity toward TNF-α, we developed a bioassay based on homo-
quenching of fluorescence.
160,161
 Upon proteolytic cleavage of fluorescein-labeled 
substrates, quenched fluorescence is recovered by separation of the cleaved fragments. In 
this assay, we measured change of fluorescence intensity during proteolytic degradation 
of FITC-conjugated TNF-α. Recombinant TNF-α was covalently coupled to FITC to 
result in FITC-TNF-α (Figure 7.1A). Although degradation of TNF-α by wild type 
gingipains has been analyzed by immunoblotting,
64
 the method can only show reduction 
in the level of TNF-α, which is not clear proof of degradation. In our method, an increase 
in the fluorescence from the substrate FITC-TNF-α can occur when the homo-quenching 
is reduced. Thus, such a recovery of quenched fluorescence can be a direct evidence of 
proteolytic degradation of TNF-α by pRgpACAT−ZE. During incubation with 
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pRgpACAT−ZE, FITC-TNF-α exhibited an increase of fluorescence, while the control 
sample incubated with no enzymes showed a slight decrease (Figure 7.1B). The increased 
fluorescence was dependent on the concentration of pRgpACAT−ZE, indicating that the 









Figure 7.1 Proteolytic activity of pRgpACAT−ZE to TNF-α. (A) SDS-PAGE gel image of 
FITC-conjugated TNF-α. (B) Differences of fluorescence intensity measured at 0 min 
and 30 min (excitation: 495/9.0 nm, emission: 519/9.0 nm): FITC-TNF-α was incubated 
with no enzymes or 2.94 and 29.4 nM of soluble pRgpACAT−ZE. A medium containing 





7.3.2 Inactivation of TNF-α 
 We investigated whether biological activity of TNF-α is reduced by proteolytic 
degradation, using the TNF-sensitive L929 cells.
158
 In this step, we compared the results 
from both soluble and immobilized pRgpACAT−ZE to study effect of enzyme 
immobilization. The hybrid porous supraparticles can specifically conjugate 
pRgpACAT−ZE through the affinity between ZE/ZR coiled coils (Figure 7.2A). When the 
cells were treated with TNF-α that was digested with immobilized enzymes, 10 ~ 15% 
survival of L929 cells was observed (Figure 7.2B). In contrast, digestion of TNF-α with 
soluble enzymes only induced less than 2% of survival of the cells. We note that, when 
the amount of dosed TNF-α ranges from 0.1 to 10 ng/mL, 10% increase in viability of 
L929 cells corresponds to more than 90% reduction in the amount of TNF-α, according to 
the curve of TNF-α concentration and L929 cell viability (Figure 7.2C). 
 The higher inactivation of TNF-α by immobilized pRgpACAT−ZE is promising, 
but the factors that contributed to enhanced inactivation were not clear. Moreover, the 
low inactivation rate of soluble enzymes (< 2%) might contradict the results from 
proteolysis of FITC-TNF-α. To answer these questions, we tested cytotoxicity of 
pRgpACAT−ZE, which could also affect the cell viability. Both in the absence and 
presence of TNF-α (10 ng/mL), incubation of L929 cells with soluble pRgpACAT−ZE 
resulted in concentration-dependent decreases in the viability up to 9 % (Figure 7.2D), 
and a similar trend was also observed in the presence of 1 ng/mL TNF-α. Thus, 
immobilization of pRgpACAT−ZE and reduced access to cells compared to soluble 
pRgpACAT−ZE might have reduced undesired influence on cells, such as cytotoxicity. 
Soluble pRgpACAT−ZE might be involved in proteolysis of cellular components, possibly 
cell-surface receptors.
156
 Nonetheless, it is also possible that activity or stability of 






Figure 7.2 Inactivation of TNF-α by soluble and immobilized pRgpACAT−ZE. (A) 
Scheme for immobilization pRgpACAT−ZE on the porous supraparticles: ZE motif from 
the fusion protein form coiled coils with ZR motifs incorporated in the particle. (B) 
Survival of L929 cells treated with TNF-α digestion reaction mixture: absorbance from 
treatments with 0 and 10 ng/mL of TNF-α was used as references for 100% and 0%, 
respectively. No soluble enzyme or supraparticles without immobilized enzyme were 
used as controls (0 nM). (C) A curve of L929 cell viability as a function of TNF-α 
concentration. (D) Cytotoxicity of soluble pRgpACAT−ZE in the absence or presence of 





 We demonstrated proteolysis and inactivation of TNF-α by pRgpACAT−ZE. While 
soluble enzymes showed limited inactivation of TNF-α and a level of cytotoxicity to cells 
was observed, the enzymes immobilized on porous supraparticles showed enhanced 
inactivation of TNF-α. This suggests that immobilized pRgpACAT−ZE may be selective to 
soluble targets. Moreover, we believe that the supraparticles can be used as a carrier for 




CONCLUSIONS AND FUTURE OUTLOOK 
 
8.1 Conclusions and Recommendations 
 This dissertation describes self-assembly of protein-based suprastructures, which 
can incorporate folded functional proteins. Recombinant protein building blocks based on 
biomimetic motifs have been successfully produced, and self-assembled into colloidal 
suprastructures with various morphologies including spheres, vesicles, nanosheets, and 
porous particles. Manipulation of morphology was achieved by engineering of protein 
building blocks, controls in self-assembly processes, and combination of inorganic 
nanocrystals. The modular design that allows integration of diverse functional domains 
offers opportunities for practical applications. Moreover, we describe fundamentals 
involved in self-assembly, including supramolecular interactions, molecular packing, and 
interparticle interactions. We envision that they will establish a solid basis for further 
development of self-assembled protein-based biomaterials, contributing to broadening 
knowledge in this field. 
 
8.1.1 Protein Self-Assembly in the ECM 
 Fabrication of spherical protein coacervates inside the ECM can be achieved via 
designed in-situ protein self-assembly. It is mediated by spontaneous diffusion–
coacervation and high-affinity binding processes. As protein building blocks self-
assemble into particles via thermally driven inverse phase transition in the ECM, they are 
entrapped, and subsequently shrink, and release protein. The main feature of this system 
is application of the reaction-diffusion principles for protein self-assembly. Molecular 
transport and simultaneous self-assembly are considered together. Furthermore, the 
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protein coacervates are kinetically stabilized rather than thermodynamically, while 
influenced by several competing factors such as the ouzo effect, hindrance by the matrix, 
and dissociation. For future study, dynamic control of protein self-assembly and their 
functionalities in different biological matrices can be investigated. As performed in this 
study, computational modeling can provide anticipation of their distribution in matrices. 
Also, the system provides potential as a “carrier-free” protein delivery approach. 
Delivery systems with no carrier materials have newly emerged, and, for example, 
engineered growth factors with binding affinities to the ECM have been demonstrated.
162
 
Our approach will contribute to development of further strategies in this field.   
 
8.1.2 Thermally Triggered Self-Assembly of Protein Vesicles 
 We developed a versatile method for aqueous self-assembly of vesicles from 
folded proteins. It is driven by thermally triggered inverse phase transition, without any 
use of organic solvents. Folded and biologically functional proteins can be incorporated 
into vesicle membranes, and the protein vesicles can encapsulate various types of cargo 
including small molecules, proteins, and nanoparticles. These interesting properties of the 
protein vesicles are hypothesized to largely attribute to the “single-layer” vesicular 
membrane. Acquisition of direct evidences for formation of a single-layer membrane is 
highly recommended for future work. Also, in-depth investigation of the formation 
mechanism will be interesting and have an impact to the community of self-assembled 
materials. 
 In addition, stability of the vesicles is important for further applications. As 
described in Chapter 4, vesicles are considered as thermodynamically stable rather than 
kinetically trapped. As a step forward, assessment of their stability in biological fluids is 
recommended. Conditions including the presence of serum proteins or at body 
temperature will provide information about applicability of the vesicles. 
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8.1.3 Self-Assembly of Protein Nanosheets 
 Self-assembly of 2D nanosheets can be achieved under controlled processes, 
using recombinant protein building blocks. Drying-induced self-assembly results in 
formation of large protein sheets (> 180 µm in width), where and folded functional 
protein domains can be incorporated. For future study, further investigations on 
formation mechanism, molecular packing, and their mechanical properties are 
recommended. Especially, molecular packing is critical for prediction of thermodynamic 
stability. We hypothesize that lateral assembly of the protein building blocks, which is 
mediated by hydrophobic interactions, is thermodynamically favored, and this can be 
further confirmed by direct proofs about molecular packing. Also, effect of modification 
of the sequence of C10 on self-assembling behavior would be a next topic.  
 Fabrication of protein nanosheets remains underdeveloped. As discussed, only 
few examples of 2D peptide or peptoid assemblies have been demonstrated. Our 
approach using folded proteins is a new concept, and formation of large sheets is a 
promising result. Our rationale on protein design and self-assembly process will provide 
a new direction for development of strategies for fabrication of protein or peptide 
nanosheets.    
 
8.1.4 Hierarchically Structured Porous Supraparticles 
 We developed a simple method to fabricate hierarchically structured porous 
protein-inorganic hybrid supraparticles. The porous hybrid particles with complex 
morphology are prepared by interfacial assembly of self-clustering flower-shaped 
nanoparticles. Such hierarchical assembly of clustering nanoparticles into supraparticles 
has not been demonstrated,
163
 while the developed method is technically simple. Thus, 
our approach can offer a new opportunity in fabrication of complex super-colloidal 
structures. It is hypothesized that the interlocking interactions and interfacial assembly 
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result in kinetically trapped structures. The discrepancy of structural densities at the rim 
and center of supraparticles supports this hypothesis to some extent. For future work, 
further investigation on the role of kinetic and thermodynamic parameters is 
recommended, and it will strengthen the hypothesis. Also, control of supraparticles 
geometry into, for example, rods or fibers might be achieved by manipulation of the 
clustering behavior of the flower-shaped nanoparticles. 
 The incorporated protein ZR−C10−ZR provides high-affinity binding sites for 
protein immobilization. In this study, a potential protein therapeutic, pRgpACAT−ZE, was 
immobilized in the supraparticles, and showed enhanced inactivation of TNF-α. The 
supraparticles could be used as a carrier for local delivery of pRgpACAT−ZE to diseased 
sites. Applications can also include biocatalysis, biosensors, and protein delivery. For 
enzyme immobilization, stabilization and activity enhancement have not been assessed 
yet, which is recommended as a future work. 
 
8.2 Guidelines for Future Applications 
 The developed suprastructures provides a promising potential for practical 
applications. The modular design strategy enables combination of diverse biological 
functions and controlled physical properties, for a wide spectrum of applications. 
Fabrication of the suprastructures is technically simple, and they are created as general 
platforms for use of diverse therapeutic proteins. Compared to conventional methods that 
involve use of polymeric or inorganic carrier materials, the self-assembled 
suprastructures enables specific and physical incorporation of therapeutic proteins under 
biocompatible conditions. Nonetheless, application requires design and production of 
therapeutic fusion proteins, alterations in self-assembly processes, and specific methods 
for administration. In this regard, several important factors must be considered, which 
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include (1) choice of protein; (2) choice of suprastructure; (3) self-assembly protocols; 
(4) administration routes. 
 
8.2.1 Choice of Protein 
 First, a protein therapeutic can be chosen, based on desired biological functions. 
Types of protein therapeutics can include: antibodies, anticoagulant, blood factors, 
enzymes, growth factors, hormones, cytokines, and thrombolytics.
164
 In addition to 
biological activity, a critical criterion in choice of protein is whether a therapeutic protein 
can be successfully expressed, folded, and purified when it is fused with leucine zipper 
motif ZE. Fusion of ZE to folded proteins has been successful for various proteins: 
fluorescent proteins (mCherry, GFP,
50
 EGFP), biomotors (kinesin-1
52
), enzymes (Rgp, 
GST
50
), cell-adhesive proteins (fibronectin
51
), and growth factors (FGF4). Both N and C 
terminal fusion of ZE are possible in general, although position of active sites should be 
considered. Also, such proteins that exhibit activities as dimers or trimers might be less 
suitable since tethered ZE might prevent their formation. 
 
 
8.2.2 Choice of Suprastructure and Self-Assembly Protocols 
 Spherical protein coacervates, which can form in the ECM, are useful for 
application of protein therapeutics working in the extracellular environments. Growth 
factors, enzymes, or antibodies can be included, and proteins become present as either 
self-assembled particles or dissociated forms. Depending on solubility of therapeutic 
proteins, the concentration of dosed ZR–ELP needs to be adjusted for their incorporation 
into ZR–ELP coacervates. Once self-assembled coacervates form in the ECM, 
approximately 50% release of therapeutic proteins is anticipated during first 24 hr, 
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followed by long-term retention as self-assembled particles. Dissociation rates may differ 
depending on physical properties of the incorporated proteins, such as surface charge or 
hydrodynamic diameter.  
 Protein vesicles can be used as carriers for delivery of various types of cargo 
including small molecules, proteins, and nanoparticles. For encapsulation of cargo, we 
expect that hydrophobic interactions between cargo and ELP motifs are critical. Thus, 
alterations of ionic strength or use of additives may be necessary, depending of surface 
properties of encapsulated cargo. Therapeutic proteins can also be incorporated on 
vesicular membrane. Ionic strength should be altered since vesicle formation is strongly 
affected by the hydrodynamic diameter and surface properties of the therapeutic proteins. 
In general, high salt concentration (~ 1 M) is required for proteins with small effective 
head area.  
 One potential application of protein nanosheets is for cell delivery. The 
nanosheets can enable incorporation of a set of multiple proteins required for cell growth, 
including cell-adhesion proteins, growth factors, and affinity ligands. In assembly of 
those proteins into nanosheets, there is still lack of information about incorporation 
efficiency as a function of protein concentration. Thus, optimization of this process 
should be first completed to control biological functionality of the nanosheets. Cells can 
simply be deposited on the surface, and the sheets are sufficiently flexible for formulation 
of cell aggregates.
165
 However, influences of surface chemistry and mechanical properties 
of the nanosheets on growth of cells should be investigated prior to applications. 
 Lastly, the hybrid porous supraparticles are useful for application of proteins that 
interact with soluble targets. For example, enzymes can be immobilized and biocatalysis 
can be conducted inside the particles. The pores are accessible to even large 
macromolecular substrates, as the hierarchy of porous structures is beneficial for efficient 
mass transport of substrates through the particles. Antibodies or affinity ligands can also 
be incorporated and used for modulation of biological responses, for example, by 
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sequestration of cytokines or chemokines. Immobilization of proteins can be achieved by 
1 hr incubation in aqueous solution, while compositions of solution may need to altered, 
depending on requirements for protein activity. 
 
8.2.3 Administration Routes 
 Although the developed suprastructures are created from biocompatible and inert 
components, information on their fate in vivo should be first obtained for administration. 
For example, consequences from administration of the porous protein-calcium phosphate 
hybrid supraparticles may limit their use to only specific applications such as bone 
regeneration.
166,167
 To select an administration route, evaluations of biocompatibility, 
toxicity, and tolerance in various routes should be conducted. In general, micrometer-
scale structures are not suitable for intravascular administration.
24
 The suprastructures are 
at micrometer scale, and injections to local sites or topical applications to open tissues 
such as wounds are considered suitable for administration. Oral administration may be 
possible for protein vesicles or nanosheets although characterizations on their 














































*The protein domains and motifs are colored: ZR (blue), ZE (red), ELP (gray), ELP (brown), mCherry 
(pink), EGFP (green), pRgpACAT (purple).  
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APPENDIX B 










































































































































































































































































































































Sequences of the Oligonucleotide Primers Used for PCR  
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